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ABSTRACT 
 
Mesoporous silica nanoparticles (MSN) are introduced as potential agents for the 
intracellular delivery and controlled release of drugs and biomolecules.  A general review of 
the current state of the knowledge in the field is presented, including a description of the 
synthesis and control of the structural and functional properties of the material, a report of the 
interactions with living cells, and an enumeration of a variety of stimuli-responsive properties 
that have been recently developed for the material. 
 The ability to functionalize the external surface of MSN was exploited as a way to 
control the cellular uptake of the material.  The results obtained demonstrate that the 
modification of the surface of MSN with small organic groups can not only determine the 
efficiency of their endocytosis by mammalian cells, but also the mechanism by which the 
material is taken up and the possibility to escape from endosomal entrapment. 
 A modification of the synthetic procedure of MSN was developed in order to obtain a 
material with a similar particle size but larger pores than the ones of MSN.  The pore-
enlarged MSN were shown to be able to deliver large cargoes into cells such as the 
membrane-impermeable protein cytochrome c. 
 The unique structural properties of MSN were shown to provide an additional benefit 
for the biological application of this material.  It was demonstrated that, as opposed to 
amorphous silica -whose hemolytic properties are well documented-, MSN do not exhibit 
significant cytotoxic properties towards red blood cells at biologically relevant 
concentrations.  This discovery along with the abovementioned abilities to control membrane 
viii 
trafficking and to adjust the inner space of the material to the characteristics of the cargo 
molecules, allow us to propose MSN as a material with a great potential for the safe and 
controlled delivery of drugs and biomolecules into living cells. 
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CHAPTER 1. OVERVIEW 
 
 This dissertation is presented as a contribution to establish the fundamental 
requirements of design for using mesoporous silica nanoparticles (MSN) as devices for 
intracellular trafficking of biologically relevant species.   
 The dissertation is organized in six chapters.  The first chapter describes the 
organization of the dissertation.  Chapters 2 to 5 are journal articles, some of which have 
been already published and others have been submitted for publication, and chapter 6 finishes 
the dissertation with general conclusions and an overview of the work that is expected to 
follow. 
 Chapter 2 is a literature review describing the properties and preparation of MSN and 
the current state of the application of these materials to the field of intracellular drug and 
gene delivery.  Since the biomedical applications of nanostructured silica are still in their 
infancy, this chapter contributes to put together the recent advances in the area in order to 
have a clear picture of this emerging field and to show the directions that research is expected 
to take in the following years.  The contribution of the author to this article represents 
approximately a 40% of the work. 
A preliminary condition for using MSN as controllable intracellular carriers is to 
understand the mechanism by which they are internalized by cells, and the factors that 
regulate the efficiency of their uptake.  Chapter 3 is a study that addresses these questions.  
The effect of grafting a variety of functional groups on the external surface of the particles 
2 
upon the efficiency and mechanism of uptake was investigated.  The author contributed with 
approximately 90% of the presented research. 
Given the moderate pore size of MSN, their application as intracellular carriers has 
been limited to relatively small and simple molecules.  Chapter 4 describes the modification 
of the synthesis conditions of MSN to yield nanoparticles with larger pores, which were then 
successfully applied as agents for the delivery of membrane impermeable proteins into cells.  
The contribution of the author corresponds to approximately 90% of the presented research. 
Silica dust has been long recognized as a material highly toxic to red blood cells, 
causing membrane rupture in a process known as hemolysis.  Such a property represents a 
serious drawback to the proposal of using MSN as in vivo drug delivery agents.  In chapter 5 
it is demonstrated, however, that the unique structural properties of MSN inhibit the 
hemolytic properties of their constitutive material, thus eliminating a serious hurdle in the 
road to employ MSN for biomedical purposes. 
The dissertation is finished in chapter 6 with a general conclusion and an outline of 
the directions that this area of research is expected to take in the future. 
3 
CHAPTER 2. MESOPOROUS SILICA NANOPARTICLES AS CONTROLLED RELEASE 
DRUG DELIVERY AND GENE TRANSFECTION CARRIERS 
A paper accepted for publication in Advanced Drug Delivery Reviews 
Igor I. Slowing, Juan L. Vivero-Escoto, Chia-Wen Wu, and Victor S.-Y. Lin 
Abstract 
In this review, we highlight the recent research developments of a series of surface-
functionalized mesoporous silica nanoparticle (MSN) materials as efficient drug delivery 
carriers.  The synthesis of this type of MSN materials is described along with the current 
methods for controlling the structural properties and chemical functionalization for 
biotechnological and biomedical applications. We summarized the advantages of using MSN 
for several drug delivery applications. The recent investigations of the biocompatibility of 
MSN in vitro are discussed.  We also describe the exciting progress on using MSN to 
penetrate various cell membranes in animal and plant cells.  The novel concept of 
gatekeeping is introduced and applied to the design of a variety of stimuli-responsive 
nanodevices.  We envision that these MSN–based systems have a great potential for a variety 
of drug delivery applications, such as the site-specific delivery and intracellular controlled 
release of drugs, genes, and other therapeutic agents.  
4 
1. Introduction 
Over the past few decades, research breakthroughs made in designing pharmaceutical drugs 
for various diseases have greatly advanced the knowledge of physicochemical properties of 
drug molecules as well as mechanisms of cellular uptake leading to numerous effective 
therapeutic strategies.  However, in some cases, such as chemotherapy for cancer, the current 
treatment methods primarily rely on the use of conventional cytotoxic drugs that have adverse 
side effects and only limited effectiveness.  Many studies have indicated that these problems 
could be attributed to the lack of target specificity of the current state-of-the-art antitumor 
drugs.  To overcome this hurdle, a widely pursuit strategy is to design a target-specific drug 
delivery system (DDS) that can transport an effective dosage of drug molecules to the 
targeted cells and tissues.  
Obviously, the success of this approach hinges upon the ability to construct a 
biocompatible carrier that allows high loading of drug molecules without any premature 
release of the cargo before reaching the destination.  As outlined below, several perquisites 
need to be incorporated into such a material in order to serve as an efficient DDS. 
1. The carrier material should be biocompatible. 
2. High loading/encapsulation of desired drug molecules. 
3. Zero premature release, i.e., no leaking, of drug molecules. 
4. Cell type or tissue specificity and site directing ability. 
5. Controlled release of drug molecules with a proper rate of release to achieve an 
effective local concentration. 
5 
At first glance, it seems impossible to find a material that could have high affinity for 
absorbing certain drug molecules, yet it would willingly release the same cargo upon reaching 
the designated site of cells or tissues.  To circumvent this catch-22 situation, several 
biodegradable materials, such as polymeric nanoparticles, dendrimers, and liposomes, have 
been used as “smart” drug delivery systems that can controllably release pharmaceutical 
drugs in aqueous solution upon the structural degradation of the carrier triggered by various 
chemical factors, such as pH, under physiological conditions.  While several exciting DDS 
systems have been prepared following this approach, it is difficult to achieve “zero” 
premature release of drugs in these structurally unstable “soft” materials1.  In many cases, the 
matrix-entrapped drug molecules would start leaking out the biodegradable carrier as soon as 
the system was introduced in water.   
This premature release problem not only limits the usage of these biodegradable DDS 
materials for effective cancer treatment, but also presents a major challenge for the site-
selective delivery of protein- and nucleotide-based drugs via oral administration.  The 
precious pharmaceutical cargo of enzymes, DNAs, and RNAs would decompose in the highly 
acidic environment of stomach if the carrier cannot offer the necessary protection.  For these 
applications, it is critical that the drug carrier would not degrade or leak until it reaches its 
intended destination, securing the release of high local concentrations of the drug at the 
target.   
Due to the rapidly increasing importance of these applications, recent research has focused 
on developing structurally stable drug delivery systems that are able to deliver a relatively 
large amount of drug molecules without any premature release problem to targeted tissues or 
6 
even intracellular organelles.  Among many structurally stable materials that have been 
investigated for drug delivery, silica materials with defined structures and surface properties 
are known to be biocompatible.  Silica is often the material of choice to enable the biological 
use of inorganic nanoparticles
2-4
.  For example, silica-coated semiconductor quantum dots, 
such as cadmium sulfide and selenide, have been demonstrated to possess high stability, 
chemical versatility, and biocompatibility that are crucial for many biomedical applications
5,6
. 
Also, silica has been employed in the formulation of artificial implants because of the 
osteogenic properties of its composites
7
.  For controlled release applications, it has been 
shown that silica is able to store and gradually release therapeutically relevant drugs like 
antibiotics
8,9
, and others
10
.  Furthermore, silica is used to enhance the biocompatibility of 
several drug delivery systems, such as magnetic nanoparticles
11-13
, biopolymers
14
, and 
micelles
15
.  
 
2. Mesoporous Silica Nanoparticles 
2.1.  Morphology Control  
Mesoporous silicas, such as MCM-41 and SBA-15 silicas, are solid materials, which are 
comprised of a honeycomb-like porous structure with hundreds of empty channels 
(mesopores) that are able to absorb/encapsulate relatively large amounts of bioactive 
molecules.  The unique properties, such as high surface area (> 900 m
2
/g), large pore volume 
(> 0.9 cm
3
/g), tunable pore size with a narrow distribution (2-10 nm), and good chemical and 
thermal stability, of these materials make them potentially suitable for various controlled 
release applications.   
7 
Since the discovery of surfactant-templated synthesis of mesoporous silica materials in 
1992
16
, many have explored the functionalization and utilization of these materials for 
various applications, such as catalysis
17
, separation
18
, and sensors
18
.  Despite these exciting 
advancements, there was no report on the utilization of these materials for controlled release 
and delivery application until the early 2000’s.  One of the possible reasons is the lack of 
morphology control.  The conventional synthetic methods for preparing mesoporous silica 
materials give rise to amorphous chunks and particles with different shapes and sizes.  The 
polydispersity and the amorphous nature of the mesoporous silicas present a major challenge 
in understanding and controlling the mass-transport properties at the nano-level, which is of 
fundamental importance for drug delivery and controlled release in biological systems. 
 
2.1.1. Particle Size 
Mesoporous Silica Microspheres: Unger, Stucky, and Zhao were among the first groups 
that made micrometer-sized mesoporous silica spheres with a narrow size distribution
17,19,20
.  
Their goal was to control the particle size and monodispersity of mesoporous silica spheres 
for chromatographic applications
18
.  Their synthesis of mesoporous silica microspheres was 
based on the well-established Stöber reaction for the synthesis of monodisperse non-porous 
silica spheres.  The reaction involved the co-hydrolysis and subsequent condensation of 
tetraethoxysilane (TEOS) and an alkyltrialkoxysilane in a mixture of ethanol, water, and 
aqueous ammonia.  Ethanol acted as a co-solvent to form a homogeneous solution, ammonia 
served as a morphological catalyst, and n-alkyltrialkoxysilane had the function of generating 
the porosity
17
.  Other groups showed later the synthesis of mesoporous silica microspheres by 
8 
using surfactant-stabilized emulsion chemistry
21
, static acidic conditions
20
, and co-surfactant 
methods
22
.  By fine-tuning the reaction conditions such as the relative amounts of reagents 
(alkoxysilane, water, and ammonia) and the reaction temperature, spheres with diameter of 
sub-micrometer to micrometer were successfully made.  Furthermore, the surface area and 
pore size of the mesoporous silica microspheres were regulated either by choosing various 
kinds of n-alkyltrialkoxysilanes or surfactants at different concentrations
21
.   
Mesoporous Silica Nanosphere (MSN): While the mesoporous silica microspheres are 
potentially useful for many non-biological functions, they are not suitable for many important 
biotechnological and biomedical applications.  For example, these materials cannot serve as 
efficient agents for gene transfection or carriers for intracellular drug delivery because 
mammalian cells cannot efficiently engulf large particles via endocytosis.  Also, mesoporous 
silica microspheres are within the size window of bacteria and could potentially trigger acute 
immune response in vivo.  To circumvent these problems, our group has developed a 
synthetic approach for preparing a series of mesoporous silica nanoparticle (MSN) materials.  
Our method took advantage of the well-known synthesis of MCM-41 type of mesoporous 
silica, where TEOS was used as a silica source, a cationic surfactant 
cetyltrimethylammonium bromide (CTAB) was used as a structure-directing agent, water was 
used as solvent, and sodium hydroxide was used as a morphological catalyst
23
.  The template 
surfactant (CTAB) was then removed from as-synthesized material either by solvent 
extraction (HCl in methanol solution) or calcination to generate pores.  A typical MSN has an 
average particle diameter around 100 nm, surface areas around 900 m
2
/g, pore sizes around 2 
nm, pore volumes around 0.9 cm
3
/g, abundant surface silanol groups (around 30 mol%), and 
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a hexagonal porous channel structure (Figure 1).  As will be discussed later, our group has 
developed several methods to control the morphology, pore size and surface functionalization 
of MSN. 
The following unique properties of MSN have attracted a lot of research attention for 
various controlled release delivery applications. 
1. Tunable particle size.  The particle size of MSN can be tuned from 50 to 300 nm 
allowing a facile endocytosis by living animal and plant cells without any 
significant cytotoxicity. 
2. Stable and rigid framework.  Compared to other polymer-based drug carriers, 
MSN is more resistant to heat, pH, mechanical stress, and hydrolysis-induced 
degradations. 
3. Uniform and tunable pore size.  The pore size distribution of MSN is very narrow 
and the pore diameter can be tuned between 2 to 6 nm.  These features allow one 
to adjust the loading of different drug molecules and to study the kinetics of drug 
release with high precision. 
4. High surface area and large pore volume.  As mentioned previously, the total 
surface area (> 900 m
2
/g) and pore volume (> 0.9 cm
3
/g) are very large, which 
allows high loadings of drug molecules. 
5. Two functional surfaces.  MSN have an internal surface (i.e., cylindrical pores) 
and an external surface (i.e. exterior particle surface).  This characteristic allows 
the selectively functionalization of the internal and/or external surfaces of MSN 
with different moieties. 
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6. Unique porous structure.  Many drug delivery materials have interconnecting 
porous structures, such as dendrimers with branching porous structure and 
liposomes with a large void core and a porous shell.  A “perfect” capping is 
necessary in order to achieve the desired “zero premature release” of drug because 
the pore-encapsulated guest molecules can leak through the interconnecting 
porous matrix when some of the pores are not capped.  In contrast, MSN is 
comprised of honeycomb-like, 2D hexagonal porous structure with cylindrical 
pores running from one end of the sphere to the other (Figure 1).  There is no 
interconnectivity between individual porous channels.  This unique feature 
renders the “no-leaking” capability even in the case of incomplete capping, 
meaning that the individual cylindrical pores can still serve as independent 
reservoirs for drug encapsulation and release, as long as both ends of a given 
channel are capped. 
Other Mesoporous Silica Nanospheres: Ying and co-workers recently reported a 
fluorocarbon-surfactant-mediated synthesis for MSN
22
.  The particle size of the material was 
tuned from 50 to 300 nm, and different types of mesostructures including 3D cubic, 2D 
hexagonal, foamlike, and disordered (named IBN series) were successfully produced.  The 
Bein group recently reported on the synthesis of a colloidal mesoporous silica (CMS) 
material by introducing triethanolamine (TEA) to the condensation reaction of TEOS.  By 
tuning the ratio of TEOS to TEA, they demonstrated that the particle size of CMS could be 
varied from 50 to 100 nm with a high surface area (> 1000 m
2
/g) and a large pore volume (~1 
cm
3
/g).  The pore geometry in CMS is unique, where the pores grow radially from the center 
11 
of the particle to the periphery
24
.  Okubo and co-workers used ethylene glycol (EG) in their 
synthesis in order to improve structural order and to control particle size and morphology
25
.  
The pore size of their MSN is around 2 nm when using CTAB as the structure-directly agent.  
In contrast, we recently demonstrated that MSN with adjustable pore sizes ranging from 3 to 
6 nm could be synthesized by including mesitylene as a pore-expander
26
. 
 
2.1.2. Particle Shape 
Particle shape has been shown to have an effect on the agglomeration and circulation 
properties of several non-porous nanoparticles in vitro
27,28
.  To investigate how the different 
particle shapes impact the MSN material, we have developed various methods to tune the 
particle morphology of these mesoporous silica materials.  The first method involved the use 
of a series of antimicrobial room-temperature ionic liquids (RTIL’s) with various alkyl chain 
lengths as templates for the synthesis of MSN
29
.  Spheres, ellipsoids, rods, and tubes were 
successfully synthesized by using 1-alkyl-3-methylimidazolium with different alkyl chains.  
Interestingly, a rod-shaped MSN with a pseudo-moiré rotational pattern of mesopores was 
observed in the case of using an achiral 1-octadecyl-3-methylimidazolium as surfactant 
template, yet the parallel channels were twisted into a helical structure along the long axis of 
the MSN nanorods.  This type of helical mesoporous structures were first observed by 
Tatsumi, Terasaki, and co-workers using chiral surfactants as templates
30
.  It is notable that, 
in our case, an achiral RTIL template could also give rise to the helical porous structure.  We 
also demonstrated that the antimicrobial activity of these RTIL containing MSNs could be 
tuned by modifying the morphology of these nanoparticles. 
12 
The second method was based a co-condensation reaction with TEOS and different 
organoalkoxysilanes.  For example, when TEOS was co-condensed with 3-
aminopropyltrimethoxy-silane (APTMS), a curved hexagonal tubular structure was produced.  
Interestingly, upon replacing the APTMS with other structurally similar organoalkoxysilanes, 
such as N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AAPTMS) and 3-[2-(2-
aminoethylamino)ethylamino]propyltrimethoxy-silane (AEPTMS), the particle shapes 
transformed into twisted columns and micrometer-sized spheres, respectively.  The effect of 
other co-condensing species on morphology was studied in detail, which enabled us to 
control the formation of MSN with different particle shapes
23
. 
The third method to control particle morphology was done by tuning the ratios of reactants.  
For example, by simply adding the double concentrations of the TEOS, CTAB and NaOH in 
the typical reaction mixture of regular MSN, the morphology of the nanoparticles changes 
from spheres to tubes while the pore structure and pore size remain the same.  Another 
example is the change of the ratios of AEPTMS to TEOS in the synthesis.  With the increase 
of AEPTMS/TEOS molar ratio from 1.28 to 12.8 mol%, a concurrent transformation of the 
particle morphology from small kidney-bean-shaped rods to spheres is observed, while 
elongated rods and ellipsoidal particles result at intermediate concentrations of AEPTMS
31
. 
 
2.2.  Surface Functionalization 
As outlined in Table 1, the surface of mesoporous silica materials can be modified by any 
of the following three methods: co-condensation (one-pot synthesis), grafting (post-synthesis 
modification), and imprint coating method
32,33
  
13 
Co-condensation of a tetraalkoxysilane and one or more organoalkoxysilanes has been 
widely used for producing inorganic-organic hybrid networks. The advantages of this method 
are: (a) it is applicable to a wide variety of organoalkoxysilanes; (b) it is suitable for a wide 
range of reaction conditions; (c) the coverage of functional groups is homogeneous; (d) the 
loading amount of functional groups is high without affecting dramatically the structural 
ordering of the pores. Phase separation of the precursors and the cleavage of Si-C bonds 
during the sol-gel reaction and during surfactant removal have to be avoided in the co-
condensation reactions.  We investigated the different electrostatic matching effects of 
various anionic organoalkoxysilanes, such as thiolate-, carboxylate- and sulfonate-containing 
organoalkoxysilane on the degree of organic functionalization of the MSN
34
.  By co-
condensation of two organoalkoxysilanes, we were able to introduce both acidic and basic 
functional groups into MSN
35
.  This bifunctionalized MSN possess interesting chemical 
properties that suggest a variety of novel applications.   
Grafting is commonly carried out by silylation on free (Si−OH) and geminal silanol 
(=Si(OH)2) groups.  If a high surface coverage with functional groups is desired, it is 
important to maintain a large amount of surface silanol groups after removal of the surfactant. 
Surfactant removal is usually carried out either by calcination or by appropriate extraction 
methods. Calcination promotes condensation of unreacted silanol groups, and many surface 
functional groups are lost at typical calcination temperatures (400-550°C). Extraction 
processes (e.g. with acid/alcohol mixtures for cationic surfactants or with alcohols for neutral 
surfactants) minimize loss of surface silanols. The most remarkable feature of the grafting 
method is the ability to selectively functionalize the external or the internal (pore) surfaces of 
14 
the MSN. For example, we have demonstrated that 1, 5, 6-epoxyhexyltriethoxysilane 
(EHTES) can be successfully grafted on the external surface of MSNs before the removal of 
surfactant CTAB.  The externally grafted groups can be further reacted, for example in the 
case of EHTES we were able to polymerize lactic acid on the external surface of MSN 
36
.  
Recently, Tamanoi and co-workers also modified the external surface of MSNs with 
trihydroxysilylpropyl methylphosphonate (THMP) after particle formation in order to reduce 
the aggregation and to increase the stability of the particles in aqueous solution
37
 .  
In the grafting processes above described, the silylation reagents were typically added 
under dry conditions to avoid hydrolysis and self-condensation of the reagents away from the 
surface of MSN. When silylating under anhydrous conditions the hydrophilic portion of the 
silica surface is preserved and the resulting functional groups are relatively isolated. By 
employing just enough water in the process to form a monolayer on the pore surface, more 
homogeneous coverage of organoalkoxysilanes can be obtained, leading to a higher 
concentration of functional groups in the final product
38
. 
Recently, Burleigh and co-workers reported a new imprint coating method
32
.  They coated 
the mesoporous surface of MCM-41 with ligands that were already bound to metal ions 
rather than just with the free ligands. When the metal ions were removed, the ligands were 
already positioned for complexation with metal ions of the same type. The selectivity to 
binding the original metal ions in competitive binding experiments was greater than in 
randomly functionalized mesoporous materials. 
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3. Intracellular Uptake of MSN 
In order for a material to be efficiently uptaken by non-phagocytic cells, the particle size 
of the material needs to be in the sub-micron scale
39,40
.  For intracellular drug and gene 
delivery applications, this limitation has led to extensive research efforts on designing 
materials with precise control of the particle size.  Furthermore, it is important for the drug 
carrier to have proper surface properties that can have favorable interactions with the drug 
molecules to achieve high loading.  This would allow the release of drug with high local 
concentrations at the site of interest intracellularly.  As mentioned previously, the particle 
size and surface property of MSN could be adjusted with precision for intracellular controlled 
release applications.   
Cellular uptakes of molecules are often facilitated by the specific binding between these 
species and membrane-bound receptors (e.g. LDL or transferrin receptors).  In contrast, 
materials for which cells do lack receptors can still be uptaken by constitutive “adsorptive” 
endocytosis or by fluid phase pinocytosis
39,41
.  Silica particles are known to have a great 
affinity for the head-groups of a variety of phospholipids
42
.  Therefore, the high affinity for 
adsorbing on cell surfaces that eventually leads to endocytosis is not surprising.  We and 
others have demonstrated that MSN can be efficiently endocytosed in vitro by a variety of 
mammalian cells including cancer (HeLa, CHO, lung, PANC-1), non cancer (neural glia, 
liver, endothelial), macrophages, stem cells (3TL3, mesenchymal) and others
26,37,43-46
 as 
depicted in Figure 2.  The uptake of MSN is fast.  Particles are often observed inside the cells 
within 30 minutes of introduction
43,47
.  
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3.1.  Biocompatibility 
The biocompatibility of MSN with and without surface functionalization has been tested 
by different methods.  Our studies on the viability and proliferation of various mammalian 
cells indicated that these properties were not affected by the internalization of MSN at 
concentrations below 100 µg/mL per 10
5
 cells even after 7 cell cycles.  Cell membrane 
integrity is conserved after uptake of MSN as determined by selective DNA staining followed 
by flow cytometry
43
.  Microscopic analysis shows normal cell morphology upon uptake of 
MSN.  Mitochondrial activity remains at normal levels as determined by colorimetric assay 
with 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
45,48
.  Growth rates 
for cells exposed to MSN are similar to the ones of cells grown in the absence of MSN
6,43
.  
The long-term biocompatibility and the biodegradation of MSN are not yet determined and 
understood, given the fact that this area of research is at its infancy.  Nonetheless, a recent 
report
10
 on the long-term biocompatibility of silica implants in animals has indicated that 
these materials did not present any toxic side effects for a period of 42 days. One would 
envision that MSN materials would have equal, if not better, biocompatibility than other 
silica-based materials. 
 
3.2.  Mechanism of cellular uptake 
We and other groups have used several spectroscopy techniques, including flow 
cytometry, transmission electron microscopy, and confocal fluorescent microscopy, to 
determine the cellular uptake of MSN (Figure 2 and 3)
26,43-46,49
.  In flow cytometry, the 
abundant washing of cells along with the use of extracellular fluorescence quenchers, such as 
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trypan blue, allow us to distinguish the endocytosed MSN particles from the cell membrane 
adsorbed ones.  The ability of applying Z-stacking confocal microscopy to examine both 
fixed and live cells with MSNs eliminates any false conclusion on the endocytosis efficiency 
that could be derived from the artifactual, fixation-promoted uptake.  The uptake of MSN has 
been shown to be energy-dependent by the use of metabolic inhibitors and by following the 
uptake at low temperatures
41,43,47
.   
Interestingly, even if there are no known cell surface receptors for silica, the uptake of 
MSN has been found to take place mainly through a clathrin-coated endocytosis pathway, and 
through pinocytosis, particularly for some of the surface-functionalized MSNs.  We have 
shown that, by decorating the external surface of MSN with different functionalities, one can 
control the uptake efficiency of MSN as well as their ability to escape endosomal 
compartments.  By manipulating the surface charge property (zeta potential) of MSN, we 
have demonstrated that ionic MSNs with high surface charges can easily escape endosomal 
entrapment as depicted in Figure 3.  This phenomenon could be attributed to the osmotic 
pressure produced by the high density of ions surrounding the surface of highly charged 
MSN.  We discovered that the uptake efficiency (EC50) for MSN ranges from 1 to 50 µg/mL 
per million cells depending on the chemical nature of functional groups present on the 
surface of MSN.  Also, a notable increase in the efficiency of uptake by cancer cells was 
observed upon grafting folic acid on the surface of MSN, competition experiments showed 
that the increase of uptake is associated with the participation of folic acid receptors in the 
surface of the cells.  As described above, the functionalization of MSN has been shown to 
impact their route of entry into cells as determined by the effect of a variety of chemical 
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inhibitors on the uptake observed by flow cytometry.  Clathrin pits have been identified as the 
main pathway of cell entry of non functionalized MSN and folic acid receptor mediated 
endocytosis of folic acid grafted MSN, interestingly amine and guanidinium functionalized 
MSN appear to enter cells by a clathrin and caveolae independent mechanism
43
. 
 
4.  The Gatekeeping Concept 
As mentioned previously, any drug/gene delivery system has to fulfill a list of desirable 
properties in order to achieve the release of the cargo in a suitable concentration at the desired 
target in a determined amount of time.  MSN-based stimuli-responsive systems using a 
concept of gatekeeping were first developed in our group to achieve these goals
6
.  These 
systems have the advantage of using a variety of chemical entities (like nanoparticles, organic 
molecules, or supramolecular assemblies) as “gatekeepers” to regulate the encapsulation and 
release of drug molecules (Figure 4).  This type of DDS with “zero premature release” 
performance is particularly useful when the cargo to be delivered is toxic, like anti-cancer 
drugs.  Furthermore, obtaining the ability to release drugs/genes “at will”, i.e. precise control 
over the location and timing of the release of drug, would bring a major breakthrough to 
many site-specific delivery applications.  These MSN-based stimuli-responsive controlled-
release systems have real potential in achieving such an ambitious goal. As summarized in 
Table 2, several MSN-based nanodevices have been achieved through the development of 
photochemical, pH responsive, and redox active gatekeepers.  
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4.1.  Nanoparticles as Gatekeepers 
We have recently developed a redox-controlled drug delivery system that is based on 
MSN capped with cadmium sulfide nanoparticles (CdS)
6
.  In this system, CdS was 
chemically attached to MSN through a disulfide linker, which is chemically labile and could 
be cleaved with various disulfide reducing agents, such as dithiothreitol (DTT) and 
mercaptoethanol (ME).  As a proof of priciple, vancomycin and adenosine triphosphate 
(ATP) were used as guest molecules.  The capping ability of CdS was tested by suspending 
the CdS-capped MSN in phosphate saline buffer (PBS).  After 12 hours of suspending in 
aqueous solution, no leaching of guest molecules from the CdS-capped MSN was observed.  
The release properties of the CdS-MSN system were evaluated in vitro by using different 
concentrations of reducing agents.  After addition of a disulfide reducing agent (DTT), the 
CdS-MSN systems released 54% of the loaded vancomycin, and only a 28% of the loaded 
ATP.  This variation was attributed to the different electrostatic interactions between the 
linker-functionalized MSN, which at neutral pH is positively charged because of the 2-
(propyldisulfanyl)ethylamine functionality, and the guest molecules, vancomycin (cationic at 
neutral pH) versus ATP (anionic at neutral pH).  The biocompatibility and utility of the CdS-
MSN release system was demonstrated by site-selective stimulation of astrocyte cells
6
.  ATP 
is known to induce a receptor-mediated increase in the intracellular concentration of calcium 
in astrocytes.  ATP-loaded CdS-MSN was added to an astrocyte culture in presence of Fura-2 
AM, a Ca
2+
 sensitive fluorescent dye, followed by the addition of mercaptoethanol serving as 
a trigger for the uncapping of the CdS-MSN.  After addition of the trigger, a pronounced 
increase in intracellular [Ca
2+
]i was observed by fluorescence microscopy (Figure 5).  In this 
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way, the use of CdS-MSN as a novel stimuli responsive controlled-release redox-controlled 
delivery system was demonstrated. 
The magnetic motor effect is very attractive for the development of site-directing and 
site-specific drug delivery systems.  To accomplish this goal, we have developed a redox-
controlled drug delivery system that could be moved using a commercial magnet
46
.  The 
system is comprised of a 3-(propyldisulfanyl)propionic acid-functionalized MSN (linker-
MSN).  The mesopores of this disulfide linker-MSN were capped by 3-
aminopropyltriethoxysilyl-functionalized superparamagnetic iron oxide nanoparticles 
(Fe3O4).  As a proof of principle, fluorescein was used as the guest molecule to be 
encapsulated inside the linker MSN material.  As mentioned before, the disulfide linker 
binding the MSN and Fe3O4 nanoparticles is chemically labile and can be cleaved with 
various “cell-produced” and “artificial” antioxidants, such as dihydrolipoic acid (DHLA) and 
DTT, respectively.  The release of fluorescein from the Fe3O4-MSN was tested in PBS 
solution.  After 48 hours of incubation, 85% of the total release of fluorescein (40% of the 
total loading) was attained with DTT.  With DHLA, the maximum percentage of fluorescein 
released was 31.4% of the total loading.  The amount of fluorescein released after 72 hours 
showed a similar dependence on the concentration for both of the reducing agents.  This 
result indicated that the rate of release was dictated by the rate at which the Fe3O4 
nanoparticles were removed. 
The endocytosis and biocompatibility of the system was investigated in HeLa cells.  
DAPI-stained HeLa cells were incubated with Fe3O4-MSN, confocal microscopy of the cells 
showed green fluorescence at the same focal plane as the blue fluorescence of the DAPI-
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stained cellular nucleus; a clear indication that the Fe3O4-MSN were indeed endocytosed and 
the intracellular release of fluorescein was achieved.  Furthermore, we were able to observe 
the magnetic motor effect moving the cells across the cuvette, propelled by a commercially 
available magnet.  This combination of controlled-release properties with magnetic motor 
effects makes this system very attractive for site-specific drug delivery applications
46
. 
Gold nanoparticles (AuNP) have been widely used in biomedical and biotechnological 
applications
50
.  Recently, we reported on the synthesis of a AuNP-MSN system to deliver 
plasmid DNA vector and chemicals into isolated plant cells and intact leaves
51
.  The 
intracellular delivery in plant cells is limited because of their thick cell wall.  Some strategies 
have been successfully applied to deliver DNA into plant cells, like “gene gun bombardment” 
using DNA-coated gold microparticles as “bullets”, but this sort of systems have the 
limitation of only being able to deliver nucleic acids with small quantity due to the invasive 
nature of the bombardment, meaning many copies of DNA were damaged from the large 
sheer stress created during the cell penetration.  In contrast, the porous nature of our AuNP-
MSN system enables them to be used as a carrier of DNA and other chemicals at the same 
time.  AuNP are biocompatible capping agents; furthermore, they increase the density of the 
MSN allowing it to be used in the “gene gun” system.  We developed a redox-controlled gene 
and drug delivery system based on AuNP-MSN, which consists in the already mentioned 
disulfide linker strategy, which is used as bridge to bind the AuNP and MSN.  We were able 
to prove the utility of this system loading -oestradiol (transgene expression agent) inside of 
the channels and coating the system with an inducible GFP marker gene.  The release of -
oestradiol was triggered by DTT, resulting in the expression of the GFP vector inside of the 
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cells.  These results indicate that it was possible to deliver in a controlled manner DNA 
molecules carrying a marker gene and a chemical that is needed for its expression into plant 
cell simultaneously
51
. 
 
4.2.  Organic Molecules as Gatekeepers 
In addition to solid nanoparticles, flexible organic molecules have also been shown to be 
able to serve as gatekeepers for mesoporous silicas.  Tanaka and co-workers first reported a 
reversible photo-triggered controlled release mesoporous silica (MCM-41) system that could 
function in organic solvents
52
.  Their system took advantage of a photodimerization reaction 
of coumarin.  The pores of MCM-41 were functionalized with 7-[(3-
triethoxysilyl)propoxy]coumarin.  Given that the size of the coumarinic group is around 1.3 
nm, the dimerization of this coumarinic functionality yielded a cyclobutane coumarin dimer, 
which was large enough to close the mesoporous opening of MCM-41 silica.  The authors 
showed that both cholestane and phenanthrene could be encapsulated and released in n-
hexane solution
52
. 
Martínez-Mañez and co-workers developed an ionically-controlled mesoporous silica 
sensor
53
.  Their system is comprised of a diaminoethylenepropylsilane derivative grafted at 
the openings of the pores and a mercaptopropyl group anchored inside of the porous channels 
of the mesoporous silica.  The signal transduction mechanism is based on a colorimetric 
reaction between blue squaraine dye and the mercaptopropyl groups inside of the channels.  
The authors showed that the agglomeration/packing of the oligoamine-based “gatekeepers” 
could be manipulated by different pH’s and anions.  In the case of the pH-controlled gating, 
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an acidic solution of squaraine was introduced to the sensor.  The blue color of the squaraine 
dye remained for hours, indicating no reaction with the thiols inside the oligo-amine-gated 
pores.  The result suggested that the gate was closed because of the oligo-amines were 
protonated in the acidic solution causing a swelling between the gatekeepers.  On the other 
hand, a color bleaching of squaraine was observed in a basic solution, indicating the gate was 
opened and the thiol groups inside were accessible to react with the dye molecules
53
. 
 
4.3.  Supramolecular Assemblies as Gatekeepers 
The combination of mesoporous silica materials as solid supports and supramolecular 
assemblies as gatekeepers has resulted in novel organic/inorganic hybrid materials with 
improved functionalities.  Our group developed a dendrimer-capped MSN gene transfection 
system using a generation 2 poly(amidoamine) dendrimer (G2-PAMAM)
44
.  We 
demonstrated that this system could be used as both drug delivery and gene transfection 
agent.  We first tethered a G2-PAMAM on an isocyanatopropyl functionalized MSN to alter 
the surface charge property of the capped mesoporous silica.  This positively charged system 
was able to bind electrostatically to a plasmid DNA vector encoding for enhanced green 
fluorescence protein (EGFP).  We were able to demonstrate that G2-PAMAM-MSN protects 
efficiently the plasmid DNA against the digestion of a type-II restriction enzyme, BamHI 
(Figure 6).  The transfection efficacy, uptake efficiency, and biocompatibility of the G2-
PAMAM-capped MSN were investigated with neural glia, HeLa and Chinese Hamster 
Ovarian (CHO) cells.  The G2-PAMAM-MSN transfection efficiency to express plasmid 
DNA EGFP was compared with other commercial transfection reagents (Table 3).  Our 
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results indicated that gene transfection efficiency of G2-PAMAM-MSN was indeed better 
than those of other commercial reagents. 
Cellular uptake of G2-PAMAM-MSN was also demonstrated by fluorescence confocal 
and transmission electron microscopy (TEM).  Texas Red loaded G2-PAMAM-MSN was 
endocytosed by glia cells, fluorescence confocal micrographs showed red spots, 
corresponding to the Texas Red-loaded MSN, inside of the cells.  TEM further confirmed the 
intracellular localizations of MSN particles.  The biocompatibility of the G2-PAMAM-MSN 
system was evaluated by following cell proliferation during 6 days.  The cell growth curves 
with and without G2-PAMAM-MSN were very similar, demonstrating the high 
biocompatibility of these silica nanoparticles in vitro.  
To further investigate the controlled release properties of these capped-MSNs, our group 
was able to follow the ATP release kinetics by means of a real-time imaging system
54
.  Two 
kinds of caps were used; CdS and PAMAM (G2.5 and G4.5) were chemically attached to 
MSN through the abovementioned disulfide linker.  The method was based on luminescence 
by detecting the ATP-induced chemiluminescence of luciferase in situ.  Two different 
reducing agents, DTT and tris-(2-carboxyethyl)phosphine (TCEP), were used to release ATP 
from either CdS or PAMAM-MSN.  The results showed that DTT is a better trigger than 
TCEP to release ATP, which was rationalized in terms of the higher reducing power, the 
smaller size, and the lack of charge of DTT.  Regarding to the type of cap, this work revealed 
that CdS caps require less time to release ATP than PAMAM dendrimers.  Two main reasons 
could account for this difference.  The first one is the different capping efficiency.  Because 
of the lack of flexibility, CdS nanoparticles cannot form as many disulfide bonds as the 
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flexible PAMAM molecules.  The other explanation could be attributed to the fact that the 
diffusion of the reducing agent to the locations of disulfide “hinges” would be slow in the 
case of PAMAM-MSN because the MSN was held tighter to PAMAM than to CdS. 
Another example of supramolecular gates for mesoporous silica was developed by 
Stoddart, Zink and co-workers.  Their system is comprised of a series of electrochemical 
redox-controlled pseudorotaxanes attached to mesoporous silica, which can be switched on 
and off
55
.  In a typical case, [2]-pseudorotaxane [DNPD-CBPQT]
4+
 was used as a gatekeeper, 
which includes 1,5-dioxynaphtalene derivative (DNPD) acting as the gate post, and cyclobis-
(paraquat-p-phenylene) (CBPQT
4+
) as the movable part of the molecule.  By using Ir(ppy)3 as 
a guest molecule in a toluene/ethanol (1:1) solution, the authors were able to demonstrate the 
redox-controlled release process using NaCNBH3 as a reducing agent to open the nanovalve.  
Following the same redox-controlled release approach, the authors improved their system by 
developing a reversible nanovalve
56
.  In this later work, the authors synthesized a [2]-
rotaxane R
4+
 system, which consists of two different recognition sites in a dumbbell-type 
component.  These recognition sites are tetrathiafulvalene (TTF) and 1,5-dioxynaphtalene 
(DNP), which are separated by an oligoethyleneglycol chain incorporating a rigid 
terphenylene spacer. As in their previous work, the authors used CBPQT
4+
 as the movable 
part of the molecule.  Ferric perchlorate and ascorbic acid were used to oxidize and reduce, 
respectively the [2]-rotaxane R
4+
 nanovalve system.  In its ground state, CBPQT
4+
 ring 
prefers to encircle the TTF recognition site rather than the DNP, which is far from the 
entrances to the pores, leaving thereby the gate open.  A two electron-oxidation of the TTF 
with ferric perchlorate afforded TTF
2+
, which destabilizes its interaction with the CBPQT
4+
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ring. This produced the movement of the ring to the DNP recognition site, which is at the 
entrance of the pores closing in this way the gate.  The nanovalve was reopened upon 
reduction of the TTF
2+
 with ascorbic acid, which caused the ring to shuttle back to the more 
distant location unblocking again the pores.  As a proof of the concept the authors used 
luminescent compounds as guest molecules, which they were able to load and release by 
applying the mentioned redox triggers.   
While these controlled-release nanovalves could indeed function effectively in non-
aqueous environments, in order to apply these materials for drug delivery in vitro or in vivo, 
these systems would need to perform properly in aqueous environments, where some 
unfavorable electrostatic interaction and hydrogen bonding may inhibit the site recognition 
motifs. 
Another pseudorotaxane-based MSN controlled release system was recently reported by 
Kim and co-workers
57
.  In their work, the system consists of polyethyleneimine (PEI) as fixed 
motif and - or -cyclodextrin as the movable ring.  The authors used calcein as a guest 
molecule in PBS solution.  The working principle is based on the fact that at pH 11 the 
cyclodextrin could thread into the PEI block, thereby closing the gate.  Upon decreasing the 
pH to 5.5, the binding between PEI and cyclodextrin would be lost, which allowed the latter 
diffuse away, and thereby opening the gate.  The authors were able to prove the principle 
following the release of calcein triggered by pH. 
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5.  Controlled Release Drug Delivery 
As it has been mentioned in the previous sections, MSN-based controlled release systems 
have been demonstrated to be able to deliver different kinds of guest molecule as summarized 
in Table 2.  The loading is usually in the order of hundred milligrams per gram of MSN.  The 
ones that have been used the most are imaging agents, such as fluorescein, Texas red, and 
rhodamine B, with the main goal of testing the working principle of the stimuli controlled-
release drug/gene delivery system.  Our group has used this kind of imaging agents to 
demonstrate the performance of our stimuli-responsive MSN systems.  For instance, by using 
the aforementioned Texas Red-loaded G2-PAMAM-MSN material, we discovered that this 
system was indeed endocytosed by HeLa cells as determined by confocal fluorescent 
microscopy
44
.  Fluorescein has also been very useful in demonstrating the controlled-release 
performance of our mesoporous silica nanoparticles in solution and in vitro as highlighted in 
our work with the Fe3O4-MSN system
46
.  Also, with the help of these fluorescent dyes as 
pore-encapsulated molecules, we were able to determine the concentration effect of the gate-
opening trigger on the release kinetics of guest molecules both inside and outside of cells. 
To apply these systems for releasing biologically active molecules to living cells, we have 
investigated the CdS-MSN system for controlled release of drugs (vancomycin) and 
neurotransmitters (ATP) to live cells
6
.  The controlled-release of ATP from CdS-MSN was 
used to artificially trigger a well-studied biological process, i.e. to promote the increase in 
intracellular calcium in astrocytes.  We also used the controlled-release of ATP from CdS-
MSN and PAMAM-MSN to prove the performance of a real-time imaging method based on 
Luciferase chemiluminescence
54
. 
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Besides our group, others have also been able to release different kinds of drugs from 
mesoporous silica.  Vallet-Regí and co-workers have demonstrated the release of ibuprofen
58
, 
erythromycin
59
, and alendronate
60
 using different strategies to modify the control of drug 
release.  Very recently, Tamanoi and co-workers demonstrated the release of camptothecin 
(CPT), a hydrophobic anticancer drug, from MSN
37
.  Using confocal fluorescence 
microscopy, the authors confirmed the CPT release inside of various cancer-cell lines.  
Moreover, they were able to observe the growth inhibition and cell death, resulted from the 
delivery of CPT into the cancer cells. 
The intracellular delivery of peptides and proteins is also relevant for therapeutic 
purposes.  Recently, we demonstrated the use of pore expanded MSN to deliver a membrane-
impermeable protein (cytochrome c) into HeLa cells, thereby showing that not only small 
drugs, but also macromolecules can be delivered with MSN based systems
26
. 
Gene therapy has caught a lot of attention in medicine because it provides great 
opportunities for treating diseases, infections and cancer.  One of the main drawbacks for this 
technique is that there is not yet an efficient and safe system to deliver the therapeutic genes 
to a specific tissue or organ.  To address this issue we have evaluated our stimuli-responsive 
mesoporous silica nanoparticles as gene transfection agents.  Using our G2-PAMAM-MSN 
system, we demonstrated that our system can protect plasmid DNA vector (EGFP) against 
enzymatic cleavage and induce EGFP expression in HeLa cells
44
.  The EGFP expression was 
not only observed in mammalian cells, but also observed  in plant cells using AuNPs-MSN 
system as transfection agent, with the additional advantage of simultaneously deliver the 
corresponding transgene expression additive
51
. 
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6. Conclusion and Future Directions 
In this review, we have highlighted some exciting research progress on the utilization of 
mesoporous silica nanoparticles as intracellular controlled-release drug delivery agents.  The 
mechanisms, by which non-functionalized MSN can be transformed into stimuli-responsive 
drug delivery agents, have already been established, although further improvements are 
expected in terms of increasing the inventory of gatekeepers and controlled release 
mechanisms.  While these results are encouraging and show great potential for future 
applications, new breakthroughs are still needed for this type of drug delivery systems.  For 
example, the system has not yet been studied in vivo and therefore essential information 
regarding circulation properties in blood, possible immunogenicity, and accumulation in liver 
or specific tissues need to be obtained and, eventual problems emerging from those studies 
will need to be addressed.  Cell type specificity is a challenge that also needs to be overcome.  
Furthermore, the possibility of other therapeutic applications using MSN as an intracellular 
controlled release nanodevice could be envisioned.  For instance, it is plausible that some 
functionalized MSNs would be able to perform specific tasks inside of cells, e.g., altering 
cellular processes by sequestration or immobilization of metabolites or other functional 
biomolecules.  We look forward to seeing many exciting research accomplishments in this 
burgeoning field of nano-bio-materials.   
Acknowledgement 
The authors thank U.S. NSF (CHE-0239570), U.S. DOE, Office of Basic Energy 
Sciences (DE-AC02-07CH11358), and Plant Science Institute at Iowa State University for 
financial support. 
30 
REFERENCES  
 (1) Kwon, I. K.; Jeong, S. H.; Kang, E.; Park, K. Cancer Nanotech. 2007, 333-
344. 
 (2) Bottini, M.; D'Annibale, F.; Magrini, A.; Cerignoli, F.; Arimura, Y.; Dawson, 
M. I.; Bergamaschi, E.; Rosato, N.; Bergamaschi, A.; Mustelin, T. Int. J. Nanomed. 2007, 2, 
227-233. 
 (3) Gerion, D.; Herberg, J.; Bok, R.; Gjersing, E.; Ramon, E.; Maxwell, R.; 
Kurhanewicz, J.; Budinger, T. F.; Gray, J. W.; Shuman, M. A.; Chen, F. F. J. Phys. Chem. C 
2007, 111, 12542-12551. 
 (4) Graf, C.; Dembski, S.; Hofmann, A.; Ruehl, E. Langmuir 2006, 22, 5604-
5610. 
 (5) Zhu, M.-Q.; Han Jason, J.; Li Alexander, D. Q. J. Nanosci. Nanotechnol. 
2007, 7, 2343-8. 
 (6) Lai, C.-Y.; Trewyn, B. G.; Jeftinija, D. M.; Jeftinija, K.; Xu, S.; Jeftinija, S.; 
Lin, V. S. Y. J. Amer. Chem. Soc. 2003, 125, 4451-4459. 
 (7) Areva, S.; Aeaeritalo, V.; Tuusa, S.; Jokinen, M.; Linden, M.; Peltola, T. J. 
Mater. Sci.: Mater. Med. 2007, 18, 1633-1642. 
 (8) Meseguer-Olmo, L.; Ros-Nicolas, M. J.; Vicente-Ortega, V.; Alcaraz-Banos, 
M.; Clavel-Sainz, M.; Arcos, D.; Ragel, C. V.; Vallet-Regi, M.; Meseguer-Ortiz, C. J. 
Orthop. Res. 2006, 24, 454-460. 
 (9) Radin, S.; El-Bassyouni, G.; Vresilovic, E. J.; Schepers, E.; Ducheyne, P. 
Biomater. 2004, 26, 1043-1052. 
31 
 (10) Kortesuo, P.; Ahola, M.; Karlsson, S.; Kangasniemi, I.; Yli-Urpo, A.; 
Kiesvaara, J. Biomater. 1999, 21, 193-198. 
 (11) Dormer, K.; Seeney, C.; Lewelling, K.; Lian, G.; Gibson, D.; Johnson, M. 
Biomaterials 2005, 26, 2061-72. 
 (12) Arruebo, M.; Galan, M.; Navascues, N.; Tellez, C.; Marquina, C.; Ibarra, M. 
R.; Santamaria, J. Chem. Mater. 2006, 18, 1911-1919. 
 (13) Zhao, W.; Gu, J.; Zhang, L.; Chen, H.; Shi, J. J. Amer. Chem. Soc. 2005, 127, 
8916-8917. 
 (14) Allouche, J.; Boissiere, M.; Helary, C.; Livage, J.; Coradin, T. J.Mater. Chem. 
2006, 16, 3120-3125. 
 (15) Huo, Q.; Liu, J.; Wang, L.-Q.; Jiang, Y.; Lambert, T. N.; Fang, E. J. Amer. 
Chem. Soc. 2006, 128, 6447-6453. 
 (16) Kresge, C. T.; Leonowicz, M. E.; Roth, W. J.; Vartuli, J. C.; Beck, J. S. 
Nature 1992, 359, 710-12. 
 (17) Gruen, M.; Lauer, I.; Unger, K. K. Adv. Mater. 1997, 9, 254-257. 
 (18) Unger, K. K.; Kumar, D.; Grun, M.; Buchel, G.; Ludtke, S.; Adam, T.; 
Schumacher, K.; Renker, S. J. Chromatogr., A 2000, 892, 47-55. 
 (19) Huo, Q.; Feng, J.; Schueth, F.; Stucky, G. D. Chem. Mater. 1997, 9, 14-17. 
 (20) Qi, L.; Ma, J.; Cheng, H.; Zhao, Z. Chem. Mater. 1998, 10, 1623-1626. 
 (21) Kosuge, K.; Singh, P. S. Microporous Mesoporous Mater. 2001, 44-45, 139-
145. 
 (22) Han, Y.; Ying, J. Y. Angew. Chem., Int. Ed. 2005, 44, 288-292. 
32 
 (23) Huh, S.; Wiench, J. W.; Yoo, J.-C.; Pruski, M.; Lin, V. S. Y. Chem. Mater. 
2003, 15, 4247-4256. 
 (24) Moeller, K.; Kobler, J.; Bein, T. Adv. Funct. Mater. 2007, 17, 605-612. 
 (25) Gu, J.; Fan, W.; Shimojima, A.; Okubo, T. Small 2007, 3, 1740-4. 
 (26) Slowing, I. I.; Trewyn, B. G.; Lin, V. S. Y. J. Amer. Chem. Soc. 2007, 129, 
8845-8849. 
 (27) Bao, Y.-z.; Liao, J.-g.; Huang, Z.-m.; Weng, Z.-x. J. Appl. Pol. Sci. 2003, 90, 
3848-3855. 
 (28) Teeguarden, J. G.; Hinderliter, P. M.; Orr, G.; Thrall, B. D.; Pounds, J. G. 
Toxicol. Sci.2007, 95, 300-312. 
 (29) Trewyn, B. G.; Whitman, C. M.; Lin, V. S. Y. Nano Lett. 2004, 4, 2139-2143. 
 (30) Che, S.; Liu, Z.; Ohsuna, T.; Sakamoto, K.; Terasaki, O.; Tatsumi, T. Nature  
2004, 429, 281-284. 
 (31) Huh, S.; Wiench, J. W.; Trewyn, B. G.; Song, S.; Pruski, M.; Lin, V. S. Y. 
Chem. Comm. (Cambridge, United Kingdom) 2003, 2364-2365. 
 (32) Burleigh, M. C.; Dai, S.; Hagaman, E. W.; Barnes, C. E.; Xue, Z. L. ACS 
Symposium Series 2001, 778, 146-158. 
 (33) Chen, H.-T.; Huh, S.; Lin, V. S. Y. Catal. Prep. 2007, 45-73. 
 (34) Radu, D. R.; Lai, C.-Y.; Huang, J.; Shu, X.; Lin, V. S. Y. Chem. Comm. 2005, 
1264-1266. 
 (35) Huh, S.; Chen, H.-T.; Wiench, J. W.; Pruski, M.; Lin, V. S. Y. Angew. Chem., 
Int. Ed. 2005, 44, 1826-1830. 
33 
 (36) Radu, D. R.; Lai, C.-Y.; Wiench, J. W.; Pruski, M.; Lin, V. S. Y. J. Amer. 
Chem. Soc. 2004, 126, 1640-1641. 
 (37) Lu, J.; Liong, M.; Zink, J. I.; Tammanoi, F. Small 2007, 3, 1341-1346. 
 (38) Feng, X.; Fryxell, G. E.; Wang, L. Q.; Kim, A. Y.; Liu, J.; Kemner, K. M. 
Science 1997, 276, 923-926. 
 (39) Mayor, S.; Pagano, R. E. Nature Rev. Mol. Cell Biol. 2007, 8, 603-612. 
 (40) Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Biochem. J. 2004, 377, 
159-169. 
 (41) Xing, X.; He, X.; Peng, J.; Wang, K.; Tan, W. J. Nanosci. Nanotech. 2005, 5, 
1688-1693. 
 (42) Mornet, S.; Lambert, O.; Duguet, E.; Brisson, A. Nano Lett. 2005, 5, 281-285. 
 (43) Slowing, I.; Trewyn, B. G.; Lin, V. S. Y. J. Amer. Chem. Soc. 2006, 128, 
14792-14793. 
 (44) Radu, D. R.; Lai, C.-Y.; Jeftinija, K.; Rowe, E. W.; Jeftinija, S.; Lin, V. S. Y. 
J. Amer. Chem. Soc. 2004, 126, 13216-13217. 
 (45) Chung, T.-H.; Wu, S.-H.; Yao, M.; Lu, C.-W.; Lin, Y.-S.; Hung, Y.; Mou, C.-
Y.; Chen, Y.-C.; Huang, D.-M. Biomater. 2007, 28, 2959-2966. 
 (46) Giri, S.; Trewyn, B. G.; Stellmaker, M. P.; Lin, V. S. Y. Angew. Chem., Int. 
Ed. 2005, 44, 5038-5044. 
 (47) Huang, D.-M.; Hung, Y.; Ko, B.-S.; Hsu, S.-C.; Chen, W.-H.; Chien, C.-L.; 
Tsai, C.-P.; Kuo, C.-T.; Kang, J.-C.; Yang, C.-S.; Mou, C.-Y.; Chen, Y.-C. FASEB J. 2005, 
19, 2014-2016. 
34 
 (48) Kim, J.-S.; Yoon, T.-J.; Yu, K.-N.; Noh, M.-S.; Woo, M.; Kim, B.-G.; Lee, 
K.-H.; Sohn, B.-H.; Park, S.-B.; Lee, J.-K.; Cho, M.-H. J. Vet. Sci. 2006, 7, 321-6. 
 (49) Lu, C.-W.; Hung, Y.; Hsiao, J.-K.; Yao, M.; Chung, T.-H.; Lin, Y.-S.; Wu, S.-
H.; Hsu, S.-C.; Liu, H.-M.; Mou, C.-Y.; Yang, C.-S.; Huang, D.-M.; Chen, Y.-C. Nano Lett. 
2007, 7, 149-154. 
 (50) Daniel, M.-C.; Astruc, D. Chemical Reviews (Washington, DC, United States) 
2004, 104, 293-346. 
 (51) Torney, F.; Trewyn, B. G.; Lin, V. S. Y.; Wang, K. Nature Nanotech. 2007, 2, 
295-300. 
 (52) Mal, N. K.; Fujiwara, M.; Tanaka, Y. Nature 2003, 421, 350-353. 
 (53) Casasus, R.; Marcos, M. D.; Martinez-Manez, R.; Ros-Lis, J. V.; Soto, J.; 
Villaescusa, L. A.; Amoros, P.; Beltran, D.; Guillem, C.; Latorre, J. J. Amer. Chem. Soc. 
2004, 126, 8612-8613. 
 (54) Gruenhagen, J. A.; Lai, C.-Y.; Radu, D. R.; Lin, V. S. Y.; Yeung, E. S. Appl. 
Spectroscop. 2005, 59, 424-431. 
 (55) Hernandez, R.; Tseng, H.-R.; Wong, J. W.; Stoddart, J. F.; Zink, J. I. J. Amer. 
Chem. Soc. 2004, 126, 3370-3371. 
 (56) Nguyen, T. D.; Tseng, H.-R.; Celestre, P. C.; Flood, A. H.; Liu, Y.; Stoddart, 
J. F.; Zink, J. I. Proc. Nat. Acad. Sci. U. S. A. 2005, 102, 10029-10034. 
 (57) Park, C.; Oh, K.; Lee, S. C.; Kim, C. Angew. Chem., Int. Ed. 2007, 46, 1455-
1457. 
 (58) Vallet-Regi, M. Chem. Eur. J. 2006, 12, 5934-5943. 
35 
 (59) Doadrio, J. C.; Sousa, E. M. B.; Izquierdo-Barba, I.; Doadrio, A. L.; Perez-
Pariente, J.; Vallet-Regi, M. J. Mater. Chem. 2006, 16, 462-466. 
 (60) Balas, F.; Manzano, M.; Horcajada, P.; Vallet-Regi, M. J. Amer. Chem. Soc. 
2006, 128, 8116-8117. 
 
 
36 
Table 1. Some functional groups introduced on the surface of MSN, and the methods 
employed to produce them. 
 
Functional group Method Reference 
Ureidoalkyl co-condensation 
23,35
 
Mercaptoalkyl co-condensation, grafting 
23,34,38
 
Cyanoalkyl co-condensation, grafting 
23,34,35
 
Aminoalkyl co-condensation, grafting 
23,34,35
 
Allyl co-condensation, grafting 
23
 
Isocyanatoalkyl grafting 
34
 
Epoxyalkyl grafting 
36
 
Phosphonatoalkyl grafting 
37
 
Metal-Aminoalkyl Molecular imprinting 
32
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Table 2. Gatekeeping systems applied in the release of various molecules from MSN. 
 
Gatekeeper Stimulus Trigger Guest Molecule Ref. 
CdS-NP Redox Reducing Agent 
(DTT, ME) 
ATP,Vancomycin 
6
 
Fe3O4-NP Redox Reducing Agent 
(DTT, DHLA) 
Fluorescein 
46
 
Au-NP Redox Reducing Agent 
(DTT) 
-oestradiol,DNA 
51
 
Coumarin Photo UV light                
 ( = 310 nm) 
Cholestane, 
Phenanthrene 
52
 
Diethylenetriamine Ionic pH, anions “Blue squaraine” 53 
PAMAM Redox Reducing Agent 
(DTT, TCEP) 
ATP, DNA 
44,54
 
[2] Pseudorotaxane 
[DNPD-CBPQT]
4+
 
Redox NaCNBH3 Ir(ppy)3  
55
 
[2] Rotaxane R
4+
 Redox Fe(ClO4)3, ascorbic 
acid 
Ir(ppy)3, 
Rhodamine B 
56
 
[2] Pseudorotaxane 
PEI-CD 
Ionic pH Calcein 
57
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Table 3. Comparison of the transfection efficiency of EGFP by PAMAM-GD-MSN with the 
one by three different commercial transfection agents (Reproduced with permission from
44
, 
copyright by the American Chemical Society). 
 
Transfection Reagent % Cells Expressing Gene 
G2-MSN 35 ± 5 
PolyFect® 15 ± 2 
SuperFect® 10 ± 2 
Metafectene® 16 ± 2 
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Figure captions 
 
Figure 1. TEM images of MSNs materials recording from the direction (a) parallel or (b) 
perpendicular to the long axis of the mesochannels. 
 
Figure 2. Transmission electron microscopy images of HeLa cell with endocytosed MSN.  
(Reproduced with permission from
44
, copyright by the American Chemical Society).  
 
Figure 3. Confocal fluorescence images of fluorescein labeled MSN (green, panel a) 
endocytosed by HeLa cells co-stained with an endosome marker (FM 4-64, red, panel b) and 
nuclear dye (DAPI, blue, panel c).  The merged images (panel d) show little coincidence of 
green and red spots (giving yellow) corresponding to MSN still inside of endosomes.  As can 
be observed, some MSN (green) have already escaped from the (red) endosomes. 
 
Figure 4. Representation of an MSN loaded with guest molecules and end-capped with a 
general gatekeeper. 
 
Figure 5. (a) Images showing that application of ME on an astrocyte culture loaded with the 
intracellular Ca
2+
-chelating fluorophore (Fura 2-AM) without the presence of MSN failed to 
produce any [Ca
2+
]i response of astrocytes. (b) Pseudo-color image of astrocytes taken after 
the ME application showed no increase or decrease in [Ca
2+
]i of the cells. (c) The same cells 
responded to the perfusion application of 100.0 µM ATP indicated by the increase of 
fluorescence intensity of the pseudo-color image of astrocytes, i.e., [Ca
2+
]i increases.  
(Reproduced with permission from
6
, copyright by the American Chemical Society) 
 
Figure 6. Fluorescent microscopy images of HeLa cells treated with G2-MSN-DNA 
complexes that have first been exposed to BamH I. (a) HeLa cells with green fluorescent 
proteins expressed in spite of the exposition to the endonuclease. (b) Phase contrast image of 
the same region of interest. (Reproduced with permission from
44
, copyright by the American 
Chemical Society).  
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CHAPTER 3.  EFFECT OF SURFACE FUNCTIONALIZATION OF MCM-41 TYPE 
MESOPOROUS SILICA NANOPARTICLES ON THE ENDOCYTOSIS BY HUMAN 
CANCER CELLS 
A paper published in the Journal of the American Chemical Society, 
2006, 128, 14792-14793. 
Igor I. Slowing, Brian G. Trewyn and Victor S.-Y. Lin 
 
Abstract 
We have synthesized a series of MCM-41 type mesoporous silica nanoparticles (MSN). 
The surface of the MSNs are functionalized with 3-aminopropyl (AP), N-(2-aminoethyl)-3-
aminopropyl (AEAP), and N-folate-3-aminopropyl (FAP). In contrast to the zeta potential of 
-18.4 mV of FITC-MSN, the values of ζ-potential for AP-, GP-, GEGP, and FAP-
functionalized FITC-MSNs in 100 mM PBS buffer (pH 7.4) increased positively from -11.3, 
-10.6, -4.0, to +4.9 mV, respectively. The uptake efficiency, endocytosis mechanism, and 
biocompatibility of these organically functionalized MSNs were investigated with human 
cervical cancer cells (HeLa). Flow cytometry results suggested that the endocytosis of MSN 
could be manipulated by different surface functionalization. The immunocytochemistry study 
indicated that the uptake of these MSNs by HeLa cells was surface functional group 
dependent and involved several different mechanisms of endocytosis. Confocal fluorescence 
micrographs showed that the different surface functionalities of MSNs could also affect their 
ability to escape endosomal entrapment, which is a key factor in designing effective 
intracellular delivery vehicles. 
47 
Recent studies on the interaction between surface-functionalized inorganic nanoparticles 
and animal cells have shown great potential for utilizing these size-defined nanomaterials for 
various biomedical and biotechnological applications, such as cell type recognition, disease 
diagnosis, intracellular imaging, and drug/gene delivery.  In particular, several recent 
reports,
1-5
 including our own studies, have shown that mesoporous silica nanoparticles can be 
efficiently endocytosed by mammalian cells.  The large surface areas and pore volumes of 
these materials offer the possibility of encapsulating and delivering large quantities of 
biogenic molecules through different cell membranes and to various intracellular targets.  
Furthermore, it has been demonstrated recently that the mesopores of these nanoparticles can 
be closed and opened at will by various capping/release strategies.
1,3,6
  These new 
breakthroughs make the surface-functionalized MSNs excellent candidates for intracellular 
controlled release delivery.  To realize this goal, an important prerequisite would be to 
understand the mechanism of cellular uptake of these surface-functionalized mesoporous 
silica nanoparticles, so that the uptake of MSNs by different cell types can be regulated. For 
example, to use these MSNs as efficient intracellular delivery vehicles, it would be important 
to use different surface functional groups to manipulate the rate of escape of MSNs from 
endosomes to cytosol and other intracellular organelles. To the best of our knowledge, no 
report has examined the effect of surface functional groups to the cell uptake properties of 
these mesoporous silica-based nanoparticles.  Herein, we report on the synthesis of a series of 
organically functionalized MSNs and investigate the mechanism and efficiency of 
endocytosis of these materials with different charge profiles on human cervical cancer cells 
(HeLa).   
48 
First, we synthesized a fluorescein-functionalized, MCM-41 type mesoporous silica 
nanoparticle material (FITC-MSN).
7
 As shown in Figure 1, FITC-MSN has an average 
particle diameter of 150 nm.  The MCM-41 type mesoporous structure with a 2.4 nm average 
pore diameter and a surface area of 850 m
2
/g was confirmed by powder x-ray diffraction 
(XRD), nitrogen sorption isotherms, and scanning and transmission electron microscopy 
(SEM and TEM, respectively) measurements.
7
  Three functional groups, 3-aminopropyl 
(AP), N-(2-aminoethyl)-3-aminopropyl (AEAP), and N-folate-3-aminopropyl (FAP), were 
grafted onto the external surface of the FITC-MSN by refluxing 6 mmol of the corresponding 
trimethoxysilyl derivatives with 1 g of FITC-MSN in toluene for 20 h.  The amino groups of 
the 3-aminopropyl and the N-(2-aminoethyl)-3-aminopropyl were transformed into 
guanidinopropyl (GP) and 3-[N-(2-guanidinoethyl)guanidinio]-propyl (GEGP) groups, 
respectively, via a literature procedure.
8
 The amount of surface-anchored AP, GP, GEGP, and 
FAP groups were determined by solid-state direct polarization 
29
Si NMR to be 1.5, 1.3, 0.97, 
and 0.89 mmol/g, respectively. After the grafting of these groups, the surfactant template 
(CTAB) molecules were removed from the MSNs by refluxing 1.0 g of the materials in 100 
mL of methanol and 1 mL of concentrated HCl. 
In contrast to the zeta potential (ζ-potential) of -34.73 mV of FITC-MSN, the values of ζ-
potential for AP-, GP-, GEGP-, and FAP-functionalized FITC-MSNs in 100 mM PBS buffer 
(pH 7.4) increased positively from -4.68 to +12.81 mV, respectively, as outlined in Table 1. 
To examine the biocompatibility of MSNs, we compared the cell growth profiles of HeLa 
cultures with and without MSNs (0.1 mg/mL) for four days.  Our results showed no 
difference in growth with or without the MSNs.
7
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To investigate the uptake of these organically functionalized MSNs, different 
concentrations of MSNs were introduced to HeLa cell cultures seeded at 1.0  105 cells/mL 
for 10 h in serum-free media. The degree of endocytosis was determined by quantifying live 
cells that exhibited green fluorescence with flow cytometry. To ensure the fluorescence 
observed in the flow cytometry measurements was indeed from the MSNs that have been 
endocytosed, a fluorescence quencher, Trypan Blue, was included in the cell suspension. 
Since Trypan Blue cannot penetrate the membranes of living cells, it could only quench the 
fluorescence of those MSNs that are adsorbed on the exterior surface of cells.
9
 The plots of 
the logarithms of the concentrations of MSNs versus the percentages of cells that took up the 
MSNs, showed a sigmoidal behavior, which is typical of dose-response endocytosis (Figure 
2a). The degrees of uptake of these MSNs were determined by their ED50 values. 
The uptake of non-functionalized, negatively charged silica materials by cells has been 
found to occur through a non-specific adsorptive endocytosis,
5
 and that the resting potentials 
of cell membranes are normally negative (-50 mV for HeLa).
10
 The relationship between the 
EC50 values and the ζ-potentials of these surface-functionalized MSNs was summarized in 
Table 1. Flow cytometry results suggested that the endocytosis of MSN could be manipulated 
by different surface functionalization. In addition to the surface charge effect, it is well 
known that the membranes of human cancer cells are abundant with folate receptors.
11
 The 
folate groups on FAP-MSN could also play an active role in facilitating a receptor-mediated 
endocytosis. 
To investigate the possible mechanism of endocytosis of the different MSNs, we tested the 
cellular uptake of these materials in presence of specific inhibitors. Our results indicated that 
50 
only the FITC- and FAP-MSNs are endocytosed via a clathrin-pitted mechanism, as the 
uptakes were inhibited by 450 mM sucrose (Figure 2b and c). In addition, the uptake of FAP-
MSN was partially inhibited in presence of 1 mM folic acid, where the endocytosis of FITC-
MSN was not perturbed (Figure 2b). This observation along with the higher uptake observed 
for FAP-MSN suggests that the mechanism of endocytosis for this material is mediated by 
folic acid receptors on the HeLa cell surface. In contrast, the endocytosis of AP- and GP-
MSNs was affected by a caveola inhibitor, Genistein (Figure 2c) suggesting that these 
materials were endocytosed via a caveolae-mediated mechanism. The uptake mechanism of 
GEGP remains unclear because the endocytosis was not dramatically affected by any of the 
inhibitors. 
To study the impact of surface functionality in endosome escape, we stained the endosomes 
with a red fluorescent endosome marker (FM 4-64) and monitored the confocal fluorescence 
micrographs (Figure 3)
7
 of FITC-MSNs with different functional groups in HeLa cells. The 
green fluorescent spots observed in Figure 3a represent the FITC-MSNs that were able to 
escape endosomes, whereas those that were entrapped inside of the vesicles exhibited yellow 
in color, which is the result of overlapping red (endosome) and green (MSN) spots. We found 
that the more negatively charged FITC- and AP-MSNs appeared to be able to escape from 
endosomes within 6 h, while those with more positive ζ-potentials, such as GP-, GEGP- and 
FAP-MSNs, remained trapped within endosomes.
7
  This behavior could be attributed to the 
proton-sponge effect,
12
 where the more negatively charged materials would have a better 
buffering capacity, which is important for the endosome escape.
12
 
51 
In conclusion, we have demonstrated the uptake of MCM-41 type mesoporous silica 
nanoparticles by HeLa cells can be regulated by different surface functionalization. Our 
results indicated that these surface functionalities could also affect MSN’s ability to escape 
endosomal entrapment, which is a key factor in designing effective intracellular delivery 
vehicles. 
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Table 1. Zeta potentials and EC50 for cellular uptake of the MSNs 
Material ζ-Potential [mV] EC50 (g/mL) 
FITC-MSN -34.73 ± 3.50 12.35 
AP-MSN -4.68 ± 1.54 10.95 
GP-MSN -3.25 ± 0.275 8.8 
GEGP-MSN +0.57 ± 0.095 6.39 
FAP-MSN +12.81 ±1.60 2.73 
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Figure captions. 
 
Figure 1. Schematic representation of the endocytosis of organically functionalized 
mesoporous silica nanoparticles (MSN) by a human cervical cancer cell (HeLa).  (a) TEM 
image of a fluorescein functionalized MSN (FITC-MSN). 
 
Figure 2. (a) Uptake of the synthesized MSN as a function of their concentration: FITC- 
(black hollow circles), AP- (red triangles), GP- (green rhombi), GEGP- (blue circle), and 
FAP- (purple square) MSN.  (b) and (c) Uptake of the materials in absence (blue bars), and 
presence of a series of inhibitors: 450 mM sucrose (prune); 1mM folic acid (gray); 200 mM 
genistein (cream). 
 
Figure 3. Confocal fluorescence images of HeLa cells stained with FM 4-64 and 40 µg/mL 
suspensions of (a) FITC-MSN and (b) FAP-MSN after 6 h of introduction.  The fluorescent 
images show the MSN (green, left) and FM 4-64-labeled endosomes (red, right).  The merged 
images are shown in the center panel. 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Appendix: Supporting information 
1.  Experimental: 
1.1.  Materials 
Tetraethylorthosilicate was purchased from Gelest.  3-aminopropyltrimethoxysilane, 3-[N-
(2-amino-ethyl)amino]propyltrimethoxysilane, fluorescein isothiocyanate isomer I, folic acid, 
1-H-pyrazole carboxamidine hydrochloride, diisopropyl ethylamine, and N-ethyl-N-(3-
dimethylaminopropyl)carbo-diimide hydrochloride were purchased from Aldrich.  All 
chemicals were used as received. 
 
1.2.  Synthesis of fluorescein isothiocyanate-labeled mesoporous silica nanoparticles 
(FITC-MSNs) 
FITC-MSN was prepared by reacting 500 mg (1.11 mmol) of fluorescein isothiocyanate 
with 0.2 mL (1.15 mmol) of (3-aminopropyl)trimethoxysilane (APTMS) for 2 h. The 
resulting product was introduced to a co-condensation reaction of 10.0 mL (43.9 mmol) 
tetraethylorthosilicate (TEOS), 2.04 g (5.32 mmol) cetyltrimethylammonium bromide 
(CTAB), 960 mL water, and 7.0 mL sodium hydroxide (2 M).  The reaction mixture was 
heated at 80 ºC, under vigorous stirring for 2 h.  The resulting orange colored solid was 
filtered, washed thoroughly with methanol and dried under vacuum for 20 h. 
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1.3. Synthesis of trimethoxysilylated FAP precursor (FAPTMS) 
Following a literature procedure,
1
 folic acid (66 mg, 0.15 mmol) was mixed with 150 mg 
(0.94 mmol) of N-ethyl-N’(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) in 10 
mL of dimethylsulfoxide.  After 30 minutes of stirring, APTMS (30 µL, 0.17 mmol) was 
added to the solution.  The reaction was stirred at room temperature for 4 h.  To avoid 
undesired hydrolysis of the FAPTMS, the DMSO solution was directly used for the grafting 
reaction described below without purification.   
 
1.4. Synthesis of surface functionalized FITC-MSNs 
3-Aminopropyl (AP), 3-[N-(2-aminoethyl)amino]propyl (AEAP), and 3-(N-
folateamino)propyl (FAP) functionalized FITC-MSNs were prepared by grafting 6 mmol of 
the trimethoxysilylated precursors, APTMS, AEAPTMS (both were purchased from 
Aldrich), and the aforementioned FAPTMS, respectively, to the surface of FITC-MSN (1 g) 
in refluxing toluene (100 mL) for 20 h.  The resulting materials were filtered, washed with 
methanol and dried under vacuum for 20 h.  The success of the surface functionalization and 
the quantification of organic groups were examined by solid-state 
13
C and 
29
Si NMR 
spectroscopy (Section 2.4). 
 
1.5.  Removal of the CTAB surfactant from the organically functionalized FITC-MSNs 
The CTAB surfactant was removed from each of the aforementioned materials by heating 
the mixture of 1.0 g of the MSN material in 100 mL of methanol and 1.0 mL of concentrated 
                                                          
1
.  Leamon, C.P.; Low, P.S. Proc. Natl. Acad. Sci. USA 1991, 88, 5572-5576. 
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hydrochloric acid for 6 h at 60 ºC.  The surfactant-removed materials were centrifuged, 
washed several times with methanol and dried under vacuum for 20 h. 
 
1.6.  Synthesis of GP- and GEGP-functionalized FITC-MSNs 
GP-functionalized FITC-MSN: 3-Guanidiniopropyl (GP) derivatized FITC-MSN was 
prepared by stirring 0.5 g of the surfactant-removed AP-MSN with 0.3 g (2.0 mmol) of 1-H-
pyrazole carboxamidine hydrochloride (HPCA), 0.36 mL (2.1 mmol) diisopropyl ethylamine 
in 5 mL of dimethylformamide (DMF) for 24 h.  The resulting material was centrifuged, 
washed with methanol and dried under vacuum for 20 h. 
GEGP-functionalized FITC-MSN: 3-[N-(2-guanidinioethyl)guanidinio]propyl (GEGP) 
derivatized FITC-MSN was prepared by stirring 0.5 g of the surfactant-removed AEAP-MSN 
with 0.6g (4.0 mmol) of 1-H-pyrazole carboxamidine hydrochloride (HPCA), 0.72 mL (4.1 
mmol) diisopropyl ethylamine in 5 mL of dimethylformamide (DMF) for 24 h. The resulting 
material was centrifuged, washed with methanol and dried under vacuum for 20 h. 
61 
2. Characterizations 
2.1.  Nitrogen adsorption/desorption isotherms 
Surface analysis of the materials was performed by nitrogen sorption isotherms in a 
Micromeritics ASAP2000 sorptometer.  The surface areas were calculated by the Brunauer-
Emmett-Teller (BET) and the pore size distribution were calculated by the Barrett-Joyner-
Halenda method. 
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Figure S1. BET nitrogen adsorption/desorption isotherms (left), and BJH pore size 
distribution (right) of the MSN materials. 
 
 
Table S1. Surface properties of the MSN materials 
Material 
BET Surface 
Area [m2/g] 
Average Pore Width 
[Å] 
Pore Volume 
[cm3/g] 
FITC-MSN 850 24 0.799 
AP-MSN 706 19 0.636 
GP-MSN 645 19 0.570 
GEGP-
MSN 
623 19 0.522 
FAP-MSN 177 <17 0.195 
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2.2.  Powder X-ray diffraction 
X-ray diffraction patterns were obtained in a Scintag XDS-2000 powder diffractometer 
using Cu Kα irradiation.  All of the materials exhibit the hexagonal mesoporous structure, 
which is typical of MCM-41 with the characteristic (100) peak between 2.10 and 2.20 
degrees (2).  The high ordered (110) and (200) peaks are also observed in these organically 
functionalized FITC-MSNs. 
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Figure S2.  (A) The X-Ray diffraction patterns of the prepared materials from 1.5 to 10 
degrees (2). (B) Enlarged view of the (110) and (200) peaks between 2.7 and 7.0 degrees  
(2). 
 
2.3.  ζ-Potential measurement 
The ζ-potentials of these MSN materials were measured in a Malvern Nano HT Zetasizer.  
Each material was tested in triplicate.  Suspensions (200 µg/mL) of each material in PBS 
buffer were prepared.  The pH of the PBS buffer was 7.69 (40 mg KCl, 40 mg KH2PO4, 
1.600g NaCl and 0.432g Na2HPO4
.
7H2O per liter of nanopure water.)  The ζ-potential was 
measured immediately after ultrasonication for 15 min.  For the ζ-potential measurements of 
FITC-, AP- and FAP-MSN, 30 scans were taken per sample, while for the ζ-potential 
measurement of GP- and GEGP-MSN, the number of scans was reduced to 10 to avoid any 
(A) (B) 
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deposition of the GP- and GEGP-MSNs on the surface of electrodes.  Figure S3 shows zeta-
potential graphs. 
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Figure S3.  ζ-potential graphs of (A) FITC-MSN, (B) AP-MSN, (C) GP-MSN, (D) 
GEGP-MSN, and (E) FAP-MSN in 10 mM PBS buffer pH 7.69. 
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2.4.  Solid state NMR 
Solid-state 
13
C and 
29
Si crossed polarization and direct polarization magic angle spinning 
NMR (CP- and DP-MAS NMR) measurements of MSNs were conducted by using a Bruker 
MSL-300 spectrometer with a Bruker 4 mm rotor MAS probe. 
 
2.4.1.  MAS 13C-NMR 
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Figure S4. 1H13C cross polarization (CP) solid-state NMR spectra of the functionalized 
materials: (A) AP-MSN, (B) GP-MSN, (C) GEGP-MSN and (D) FAP-MSN. 
 
All spectra showed a small signal around 50 ppm, which is due to surface-adsorbed 
methanol from the washings.  The smaller signals between 80 and 160 ppm correspond to the 
co-condensed FITC-APTMS.  The signals at 160 and 161 ppm in (B) and (C), respectively, 
correspond to the guanidine carbons.  No peaks of residual CTAB surfactant were observed 
in these measurements. 
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2.4.2.  MAS DP 29Si-NMR  
(A)       (B)  
(C)    (D)  
(E)  
Figure S5. Direct polarization (DP) solid-state 29Si-NMR spectra of all the materials: (A) 
FITC-MSN, (B) AP-MSN, (C) GP-MSN, (D) GEGP-MSN and (E) FAP-MSN. 
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Table S2. Composition of the materials as calculated from the DP 29Si-NMR analysis. 
Material Formula Loading 
[mmol/g] 
FITC-MSN (SiO2)100(H2O)25(FITC*)5 0.575 
AP-MSN (SiO2)100(H2O)13(FITC)5(C3H6NH2)14 1.507 
GP-MSN (SiO2)100(H2O)7(FITC)5(C3H6NHC(NH)NH2)13 1.344 
GEGP-MSN 
(SiO2)100(H2O)12(FITC)5(C3H6N(CNHNH2)C2H4NHC(NH)NH2)1
0 
0.970 
FAP-MSN (SiO2)100(H2O)5(FITC)5(C3H6NHC19H18N7O5)13 0.891 
* FITC = C3H6NHSC21H11NO5 
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2.5.  Scanning electron microscopy 
Particle morphology was investigated by using a JEOL 840A scanning electron microscope 
with a 10 kV acceleration voltage. 
 
Figure S6. Scanning electron micrographs (SEMs) of (A) FITC-MSN, (B) AP-MSN, (C) 
GP-MSN, (D) GEGP-MSN, and (E) FAP-MSN.  The scale bars are 500 nm.  These materials 
are spherical particles ranging from 100 to 250 nm in diameter. 
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3.  Measurement of uptake of the materials by HeLa cells 
The cellular uptake profiles of all MSNs were examined by FACS flow cytometry and 
fluorescence confocal microscopy. 
3.1.  Flow cytometry 
For the flow cytometry assays, HeLa cells were seeded in six well plates with a density of 1 
× 10
5
 cells/mL in 3 mL of D-10 medium.  The D-10 medium is a Dubelcco modified Eagle’s 
medium (DMEM) containing 10% equine serum, L-alanylglutamine, gentamicin, and 
penicillin/streptomycin.  After 34 h incubation, the D-10 medium was replaced by 3 mL of 
MSN suspensions at different concentrations ranging from 0.1 to 40 µg/mL in the serum-free 
DMEM medium for 10 h.  Different concentrations of MSN suspensions were tested.  All the 
tests were run in triplicate.  The cells were washed then with medium and harvested by 
trypsinization.  After centrifugation the cell pellets were resuspended in 0.4 % trypan blue 
PBS solution, and analyzed by flow cytometry with a Becton-Dickinson FACSCanto 
cytometer and BD-FACS Diva software. 
To distinguish the true fluorescence generated by the FITC-MSN from the natural 
autofluorescence of cells, a threshold of fluorescence intensity was established by performing 
the flow cytometry analysis on HeLa cells incubated without any MSN.  The threshold was 
set at a fluorescence intensity slightly above the highest value observed for control samples 
(HeLa Cells only).  The number of cells with encytosed MSNs was determined by counting 
the cells showing fluorescence intensity higher than the threshold. 
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3.2.  Inhibition and competition assays 
HeLa cells were seeded at the density of 1 × 10
5
 cells/mL in 6 well plates and allowed to 
attach for 48 h in 3 mL of D-10 medium.  The D-10 medium was then replaced by 3 mL of: 
(a) DMEM medium for the wells used as control, (b) 1 mM folic acid in DMEM medium for 
the wells used in the competition assay, and (c) 450 mM sucrose in DMEM medium for the 
wells used in the clathrin inhibition assay.  The cells were left in contact with the media for 
30 min.  The media were then replaced with 3 mL of MSN (40 µg/mL) in: (a) DMEM 
medium for the control, (b) 1 mM folic acid in DMEM medium for the competition assay, 
and (c) 450 mM sucrose in DMEM medium for the clathrin inhibition assay.  After 1 h, the 
cells were washed with DMEM medium and harvested by trypsinization.  After 
centrifugation, the cell pellets were resuspended in 0.4% trypan blue PBS solution, and 
analyzed by flow cytometry with a Becton-Dickinson FACSCanto cytometer and BD-FACS 
Diva software. 
 
3.3 Cell growth and viability assays 
Cell growth and viability of the HeLa cells in the presence and absence of MSN were 
studied by Guava ViaCount assay (Guava Technologies, Inc.; Hayward, CA).  For that 
purpose HeLa cells were seeded in four six well plates with a density of 1 × 10
5
 cells/mL in 3 
mL of D-10 medium containing (a) no MSNs, (b) FITC-MSN, (c) AP-MSN, (d) GP-MSN, 
(e) GEGP-MSN and (f) FAP-MSN.  The concentration of the MSNs in the culture media was 
40 µg/mL.  After seeding them the plates were set in an incubator at 37
o
C and 5% CO2 and 
every other day, for a lapse of four days, one plate was removed from the incubator, the 
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media of each well was discarded, each well was washed with fresh D-10 medium and the 
cells trypsinized, centrifuged and resuspended in D-10 medium.  The cells in the resuspended 
media were then counted and their viability determined by the Guava ViaCount cytometry 
assay.  Figure S7 shows the results of the cell counts at every day, the viability was found to 
be between 90 and 100 %. 
0
20
40
60
80
100
120
0 20 40 60 80 100
Time [hours]
V
ia
bl
e 
C
el
ls
/m
L 
(*
10
5 )
Control FITC MSN AP GP GEGP FAP
 
Figure S7. Cell counts performed with Guava ViaCount assay after incubation at different 
times in absence and in presence of 40 µg/mL of the MSNs in D-10 media. 
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3.4.  Confocal fluorescence microscopy 
3.4.1. Localization of the MSNs inside the cells 
For confocal fluorescence microscopy measurements, HeLa cells were seeded at the density 
of 1 × 10
5
 cells per well in 6 well plates in 3 mL D-10 medium with coverslips at the bottom 
of the wells. After 34 h incubation, the D-10 medium was replaced by 3 mL of MSNs (40 
µg/mL) in the serum-free DMEM medium for 10 h.  The cell-plated coverslips were then 
washed with medium and soaked for 30 min in 3 mL of 0.4 % trypan blue in 100 mM PBS 
buffer (pH 7.4).  The trypan blue solution was then replaced by a solution of 5.7 µM 4’,6-
Diamidino-2-phenyindole (DAPI) and 3.7 % formaldehyde in 100 mM PBS buffer pH 7.44.  
The DAPI-stained coverslips were placed in microscope slides and examined under a Leica 
TCS NT confocal fluorescence microscope system using a 100x oil immersion objective.  As 
depicted in Figure S8, the blue fluorescent, DAPI-stained nuclei (right images) were clearly 
observed by exciting the cells with a UV laser at wavelengths from 340 to 458 nm.  The 
green fluorescent FITC-MSN particles inside of the HeLa cells (middle images) were 
visualized by excitation at 488nm with an Argon Laser and the phase contrast images of the 
cells (left images) were obtained with a 568nm Krypton laser. 
 
Figure S8. (See next page) Confocal fluorescence images of HeLa cells loaded with the 
different organically functionalized MSNs: (A) FITC-MSN, (B) AP-MSN, (C) GP-MSN, (D) 
GEGP-MSN, and (E) FAP-MSN.  The left images were taken with a Krypton laser source, 
the ones in the middle showed the endocytosed green fluorescent FITC-labeled MSN 
particles (Argon laser) and the right images exhibited the blue fluorescent, DAPI-stained 
nuclei (UV laser). 
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3.4.2.  Localization of the MSNs inside the cells in presence of an endosome marker 
HeLa cells were seeded at the density of 1 × 10
5
 cells per well in 6 well plates in 3 mL D-
10 medium with coverslips at the bottom of the wells. After 38 h incubation, the D-10 
medium was replaced by 3 mL serum-free DMEM medium containing MSNs (40 µg/mL) 
and the endosome marker FM 4-64 (10µg/mL) and incubated for 6 h.  The cell-plated 
coverslips were then washed with medium and soaked for 30 min in 3 mL of 0.4 % trypan 
blue in 100 mM PBS buffer (pH 7.4).  The trypan blue solution was then replaced by a 
solution of 5.7 µM 4’,6-Diamidino-2-phenyindole (DAPI) and 3.7 % formaldehyde in 100 
mM PBS buffer pH 7.44.  The DAPI-stained coverslips were placed in microscope slides and 
examined under a Leica TCS NT confocal fluorescence microscope system using a 100x oil 
immersion objective.  Both, the MSNs and the endosome marker were excited at 488 nm 
with an Argon Laser, the MSNs were detected at wavelengths in the 515 to 590 nm range 
(observed green) while the endosome marker was detected at wavelengths in the 590 to 750 
nm range (observed red).  MSNs are considered to be inside of the endosomes in the spots 
where the green and the red spots are co-localized to give a yellow color.  The phase contrast 
images of the cells (right images) were obtained with a 568nm Krypton laser. 
 
Figure S9. (See next page) Confocal fluorescence images of HeLa cells loaded with the 
different organically functionalized MSNs: (A) FITC-MSN, (B) AP-MSN, (C) GP-MSN, (D) 
GEGP-MSN, and (E) FAP-MSN, and stained with the endosome marker FM 4-64.  The 
images to the right were taken with a Krypton laser source, and the ones to the left show the 
Argon laser excited endocytosed green fluorescent FITC-labeled MSNs, the red fluorescent 
marked endosomes, and the yellow spots where the MSNs and endosomes are colocalized. 
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CHAPTER 4.  MESOPOROUS SILICA NANOPARTICLES FOR INTRACELLULAR 
DELIVERY OF MEMBRANE-IMPERMEABLE PROTEINS 
A paper published in the Journal of the American Chemical Society, 
2007, 129, 8845-8849. 
Igor I. Slowing, Brian G. Trewyn and Victor S.-Y. Lin 
 
Abstract 
A MCM-41 type mesoporous silica nanoparticle (MSN) material with a large average pore 
diameter (5.4 nm) is synthesized and characterized.  The in vitro uptake and release profiles 
of cytochrome c by the MSN were investigated.  The enzymatic activity of the released 
protein was quantitatively analyzed and compared with that of the native cytochrome c in 
physiological buffer solutions.  We found that the enzymes released from the MSNs are still 
functional and highly active in catalyzing the oxidation of 2,2’-azino-bis(3-
ethylbenzthiazoline-6-sulfonate) (ABTS) by hydrogen peroxide.  In contrast to the fact that 
cytochrome c is a cell-membrane impermeable protein, we discovered that the cytochrome c 
encapsulated MSNs could be internalized by live human cervical cancer cells (HeLa) and the 
protein could be released into the cytoplasm.  We envision that these MSNs with large pores 
could serve as a transmembrane delivery vehicle for controlled release of membrane 
impermeable proteins in live cells, which may lead to many important biotechnological 
applications including therapeutics and metabolic manipulation of cells. 
77 
Introduction 
Recent breakthroughs in the synthesis of mesoporous silica materials with high surface 
areas (> 800 m
2
/g) and tunable pore diameter (2-10 nm) have led to the developments of a 
series of new delivery systems, where various guest molecules, such as pharmaceutical drugs, 
fluorescent imaging agents, and other molecules, could be adsorbed into the mesopores and 
later released into various solutions.
1-4
 Furthermore, recent reports on the design of functional 
mesoporous silica materials by decorating the pore surface with organic or inorganic moieties 
that could serve as gating devices to regulate the release of guest molecules under the control 
of several different external stimuli, such as chemicals,
5-9
 temperature,
10
 redox reactions,
11,12
 
and photo-irradiation,
13,14
 have highlighted the potential of utilizing this kind of nanodevices 
for many controlled release applications. 
To further advance this burgeoning field of research and to use these mesoporous materials 
in practical biotechnological and biomedical applications, one key step would be to gain 
control of the particle morphology and the surface properties of these inorganic oxides, so 
that the compatibility with biological macromolecules, such as polynucleotides (DNA and 
RNA), proteins, and live cells can be enhanced.  We and others have demonstrated that, by 
controlling the particle size, shape, and surface functionality of the mesoporous silicas, these 
structurally defined materials can be efficiently endocytosed by live cells with high 
biocompatibility in vitro and serve as delivery vehicles for the controlled release of genes and 
membrane impermeable chemicals.
3,5-7
 
Also, several enzymes have been shown to be functional without being denatured inside the 
frameworks of mesoporous silicas, such as MCM-41 and SBA-15 silicas.
15-23
  However, to 
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the best of our knowledge, there were only two prior reports on the controlled release of 
proteins from SBA-15 type mesoporous silica materials under non-physiological 
conditions.
24,25
  Since the intracellular delivery of membrane impermeable proteins is an 
important research topic for understanding metabolic pathways of different cell types as well 
as for therapeutic applications, different cell penetrating molecular agents and materials, such 
as peptides,
26,27
 polymers,
28
 and carbon nanotubes,
29-31
 have been employed as carriers for 
this purpose with different degrees of success.  For example, single wall carbon nanotubes 
have been demonstrated recently to be able to deliver a cell-membrane impermeable protein, 
cytochrome c, into cells.  However, the protein-nanotube composites were unable to escape 
endosomal entrapment without the introduction of an endosome-disrupting agent, 
chloroquine, to the cells.
29
  In contrast to these prior systems, there are several advantages of 
using mesoporous silicas for intracellular protein delivery: (1) The large pore volumes (> 1 
cm
3
/g) of mesoporous silicas allow for loading vast, yet quantifiable, amounts of proteins 
into the particles.  (2) The chemically and mechanically stable inorganic oxide framework of 
mesoporous silicas shelters the protein molecules from exposure to harmful species, such as 
proteases and denaturation chemicals. (3) It has been previously observed that mesoporous 
silica nanoparticles are able to escape the endo-lysosomal entrapment.
32-34
 Therefore, the 
particles could serve not only as vehicles for introducing the proteins into the cells, but also 
to enable their release into the cytoplasm. 
Herein, we report on the synthesis and characterization of a MCM-41 type mesoporous 
silica nanoparticle (MSN) material with a large pore diameter (5.4 nm).  The uptake and 
release profiles of cytochrome c by the MSN were investigated.  To examine whether the 
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encapsulation causes any harmful effect to cytochrome c, we analyzed the enzymatic activity 
of the pore-released protein and compared with that of the native cytochrome c in 
physiological buffer solutions.  In addition, we discovered that the cytochrome c encapsulated 
MSNs could be internalized by living human cervical cancer cells (HeLa) and the protein 
could be released into the cytoplasm as depicted in Figure 1. 
 
Results and discussion 
As detailed in the supporting information, we synthesized MSN with large pores by adding 
a pore-expanding agent (mesitylene) to a CTAB-templated, base-catalyzed condensation 
reaction of silicate that we have previously reported.
35
  The template-removed mesoporous 
silica nanoparticle material is comprised of a MCM-41 type, hexagonal array of mesoporous 
channels as shown in the transmission electron micrographs (Figure 2 and Figure SI 1).  The 
powder X-ray diffraction pattern (XRD) further confirmed the hexagonal mesoporous 
structure (Figure SI 2a) with the d100 value of 71.8 Å, d110 of 40.8 Å, d200 of 35.1 Å and d210 
of 26.2 Å.  The nitrogen surface sorption analysis of the material exhibited a Type IV 
isotherm with a BET surface area of 1061 m
2
/g and a pore volume of 1.82 cm
3
/g (Figure SI 
2b).  The BJH method gave two pore size distributions centered on 5.4 nm (major peak) and 
14.5 nm (minor) (Figure SI 2c).  Of both pore distributions, the wider ones (> 10 nm) appear 
to correspond to incomplete wall formation in the outermost layer of some particles, as 
observed by TEM imaging (Figures 2b and SI 1).  Thus, the wider pores seem to be entrances 
shared by two or more of the smaller channel-type pores that run along the particles.  The 
particle size of MSN in PBS suspension was measured by dynamic light scattering.  Two 
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different particle size distributions (265 and 933 nm) were observed (Figure SI 3).  These 
particles are spherical and oval-shaped as shown in Figure 2.  
We found that the loading of cytochrome c (molecular dimensions 2.6  3.2  3.3 nm)17,36 
into the MSN was dependent to the solution concentrations of cytochrome c, which indicated 
that the encapsulation is a diffusion driven process.  As described in the supporting 
information, the amount of protein entrapped inside the MSN was determined by measuring 
the difference in concentration of cytochrome c in the supernatant before and after the 
loading of MSN.  The maximum loading was determined to be 415.0 mg of cytochrome c per 
1.0 gram of MSN at the conditions studied.  The XRD of a cytochrome c encapsulated MSN 
with a loading of 95.0 mg/g MSN could still exhibit the hexagonal symmetry of the porous 
structure with a lower contrast because of the pore-filling effect (Figure SI 4a).  Also, the 
entrapment of cytochrome c inside the mesopores was observed in the nitrogen sorption 
analysis, where the BET surface area decreased from 1061 to 290 m
2
/g and the pore volume 
reduced from 1.82 to 0.19 cm
3
/g upon loading with cytochrome c at 95 mg/g (Figure SI 4b). 
The release of cytochrome c from the MSN material at room temperature was studied by 
measuring the UV-Vis absorption profile of the Soret band (412 nm) of cytochrome c in 
supernatant after separation of the solid MSNs by centrifuge.  Two suspensions of 
cytochrome c-loaded MSN (100 µg/mL) were prepared in PBS buffer at two different pH 
values (7.4 and 5.2).  These numbers were chosen to mimic the normal pH values in the 
cytoplasm and inside endosomes.
37,38
  In both cases, a sigmoidal release curve was observed 
over a period of 25 h, which is characteristic of an energy-dependent release process.  The 
total percent of loaded proteins that were released were 45% and 55% at pH 7.4 and 5.2, 
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respectively (Figure 3).  Given that the pI of cytochrome c is 10.5 and that the surface of 
MSN is rich in silanol groups (pKa around 3), the protein is expected to be positively 
charged, while the MSN would be negatively charged at both pH values.  Therefore, for 
cytochrome c molecules to be released from the mesopores, the favorable electrostatic 
interactions between the protein and the pore-surface silicates need to be replaced by other 
ionic species in the solution similar to what has been observed in the literature.
15,16,24
  The 
observed difference in the rates of release (Figure 3) at these two pH values could be 
attributed to the different amount of negative charges on the MSN surface.  To test this 
hypothesis, we measured the change of the ζ-potential of both MSN and cytochrome c as a 
function of pH (Figure SI 5).  As expected, the ζ-potential of the protein remained almost 
constant, with very little change (between +15 and + 17 mV) between pH 5.5 to 8.0, whereas 
the ζ-potential of MSN dropped dramatically from -25.5 mV at pH 7.35 to -1.81 mV at pH 
5.22.  This confirmed the surface charge property of MSN was indeed affected by the change 
in pH. 
As shown in Figure 3, no significant release of cytochrome c from MSN was observed at 
pH 7.4 even after 4 h, while some release was observed immediately at pH 5.2.  This 
difference in the rate of release of cytochrome c allows us to introduce the protein-loaded 
MSN to cell cultures under the physiological condition without losing a large amount of 
protein in the first 4 h.  Based on the previous studies by us and others,
32-34
 human cancer and 
other animal cells are able to internalize MSN materials within 1 h.  The resulting endosome-
entrapped protein-MSN material could then release cytochrome c molecules inside the cell.   
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To examine whether the MSN-released cytochrome c can still function as an active 
enzyme, we collected proteins that were released at pH 7.4 and tested the catalytic reactivity 
for the oxidation of 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonate) (ABTS) by hydrogen 
peroxide.  We compared the enzymatic activity of the MSN-released cytochrome c with that 
of the native protein at the same concentration and under the same conditions as described in 
the supporting information.  As depicted in Figure 4, the kinetics of the two enzyme-
catalyzed reactions are essentially identical, indicating that the MSN-released cytochrome c 
could serve as an active enzyme in aqueous solutions. 
To exploit MSN as a transmembrane delivery carrier for intracellular controlled release of 
cytochrome c, we first covalently attached a fluorescent dye, fluorescein isothiocyanate 
(FITC), to the protein via a literature reported procedure.
39
  The labeling efficiency was 
determined to be 1.8 moles of FITC per mole of cytochrome c by UV-Vis absorption 
spectroscopy.  The fluorescein-labeled cytochrome c was then encapsulated inside the MSN 
by the aforementioned method described in the supporting information.  The resulting 
cytochrome c-loaded MSNs were introduced to HeLa cell cultures with the cell density of 1 × 
10
5
 cells/mL in D-10 growth medium.  The uptake of the protein-MSN material by HeLa 
cancer cells was analyzed by flow cytometry.  As shown in Figure 5, the flow cytometry 
result exhibited an efficient uptake with an EC50 of 33.6 µg/mL.  The cellular uptake of the 
material was also confirmed by confocal fluorescence microscopy.  The uptake of MSN 
observed in this work is lower than the one we observed previously for MSN of smaller pore 
size (EC50 of 12.4 µg/mL).
34
  This difference in uptake efficiency can be attributed mainly to 
the difference in particle size, for the smaller pore MSN has an average size around 150 nm, 
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while the pore enlarged MSN are larger than that.  It has been previously reported that an 
increase in the size of sub-micron particles usually leads to a decrease in the ability of cells to 
take them up.
40
  To determine whether or not the cytochrome c-loaded MSNs could escape 
the endosomal entrapment, we stained the endosomes with a red fluorescent endosome 
marker (FM 4-64)
41
 and monitored the confocal fluorescence micrographs (Figure 6) of 
FITC-cytochrome c-loaded MSNs in HeLa cells.  The green fluorescent spots observed in 
Figure 6 represent the FITC-cytochrome c-loaded MSNs that were able to escape endosomes, 
whereas those that were entrapped inside of the vesicles exhibited yellow in color, which is 
the result of overlapping red (endosome) and green (FITC-cytochrome c loaded MSN) spots. 
As depicted in Figure 6a, there were a few FITC-cytochrome c-loaded MSNs trapped inside 
of endosomes within the first 2 h.  However, as shown in Figures 6b and c no yellow spots 
could be observed in the micrographs indicating that there was no overlap between the green 
fluorescent FITC-cytochrome c and the red fluorescent endosomes.  Our results clearly show 
that the FITC-cytochrome c could escape from the endosomes efficiently within a few hours 
of endocytosis.  Interestingly, after 18 h of incubation, we observed an increasing number of 
HeLa cells displaying green fluorescence throughout their entire cell bodies (Figure 7) in 
addition to others that showed only isolated spots of green fluorescence inside the cytoplasm.  
Also, as depicted in Figure 7a, several spots with higher fluorescence intensities (FITC-
cytochrome c loaded MSN) could be observed inside the cell that displayed green 
fluorescence in the whole body.  These spots faded away with time as the green fluorescence 
intensified throughout the whole cell body (Figure 7b).  These results suggested that the 
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fluorescein-labeled cytochrome c molecules were gradually released from the conglomerates 
of MSNs and were able to diffuse throughout the entire cytoplasm. 
 
Conclusion 
In summary, we have demonstrated that the mesoporous silica nanoparticles with large 
pores can host small membrane impermeable proteins, such as cytochrome c, and release 
them under physiological conditions.  Like the native cytochrome c, the protein released from 
MSNs could also function as an active enzyme for oxidation reactions in aqueous solutions.  
These MSNs could serve as efficient transmembrane carriers to deliver cytochrome c into the 
cytoplasm of human cervical cancer cells (HeLa), while avoiding the endosomal entrapment.  
The intracellular release of the fluorescein-labeled cytochrome c was also observed by 
confocal fluorescence microscopy.  Further development of these MSN-based controlled 
release systems for protein delivery may lead to breakthroughs for many therapeutics and 
metabolic manipulation applications. 
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Figure captions 
Figure 1. Schematic representation of the MSN transporting cytochrome c through the cell 
membrane and releasing the protein into the cytoplasm. 
Figure 2.  Transmission electron micrograph of large-pore MSN. 
Figure 3. Release profiles of cytochrome c from MSN at pH 7.4 (blue rhombi) and 5.2 (red 
squares). 
Figure 4. Oxidation of 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonate) (ABTS) catalyzed 
by cytochrome c.  The blue line and markers correspond to a solution of native protein and 
the red ones to the protein released from the MSN. 
Figure 5. Uptake profile of FITC-cytochrome c loaded MSN by HeLa cancer cells. 
Figure 6. Uptake of FITC-cytochrome c loaded MSN by HeLa cancer cells as observed by 
confocal fluorescence microscopy at the following incubation times: (a) 2, (b) 14 and (c) 24 
hours.  For each set of pictures the upper left image is the autofluorescence image of the cells, 
the lower left corresponds to the green fluorescent protein taken up by the cells, the lower 
right shows the red fluorescent FM 4-64 labeled endosomes, and the upper right image is the 
merging of the green and red fluorescent images.  
Figure 7.  Confocal fluorescence images of HeLa cells displaying green fluorescence on their 
whole cell bodies, after incubation with FITC-cytochrome c loaded MSN for: (a) 18 and (b) 
26 hours.  The left pictures correspond to the autofluorescence image of the cells when 
excited at 568 nm, the middle ones to the green fluorescent labeled protein (excitation at 488 
nm) and the right ones to the merge of the first two. 
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Figure 4. 
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Figure 6. 
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Appendix: Supporting information 
 
 
 
 
 
 
 
 
 
 
 
 
Figure SI 1. (a) Scanning and (b), (c) and (d) transmission electron micrographs of large-
pore MSN. 
(a) (b) 
(c) (d) 
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Figure SI 2. (a) Small angle X-ray diffraction, (b) BET nitrogen sorption isotherms, and (c) 
BJH pore size distribution of MSN. 
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Figure SI 3. Particle size distribution of large-pore MSN suspended in 10 mM PBS pH 7.4 
measured by dynamic light scattering. 
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Figure SI 4. (a) X-ray diffraction pattern and (b) nitrogen sorption isotherm of MSN loaded 
with cytochrome c (95 mg/g). 
 
 
 
 
 
 
 
 
 
 
 
Figure SI 5. Variation of the ζ-potential of MSN (blue rhombi) and cytochrome c (red 
squares) as a function of pH. 
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Experimental Section 
1. Materials 
Horse heart cytochrome c, fluorescein isothiocyanate isomer I, mesitylene, 
cetyltrimethylammonium bromide, and 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonate) 
were purchased from Sigma-Aldrich.  Tetraethyl orthosilicate was purchased from Gelest.  
FM 4-64 endosome marker was purchased from Molecular Probes, Inc.   All chemicals were 
used as received. 
 
2. Synthesis of mesoporous silica nanoparticle (MSN) with large pores.   
Cetyltrimethylammonium bromide (CTAB, 1.0 g, 2.7 mmol) was dissolved in a solution of 
480 mL water and 3.5 mL of 2M NaOH (aq).  Mesitylene (7.0 mL, 48.8 mmol) was then 
added to the solution.  The mixture was stirred vigorously at 80 C for 2 h.  Tetraethyl 
orthosilicate (5.0 mL, 21.9 mmol) was then added dropwise at a rate of 1 mL per min to the 
solution.  The reaction mixture was stirred vigorously at 80 C for another 2 h.  The resulting 
white precipitate was isolated by filtration, washed with abundant methanol, and dried under 
vacuum at 100 C for 12 h.  The structure-templating CTAB and mesitylene molecules were 
removed from the composite material via acidic extraction. A suspension of 1.0 g of the as 
synthesized material was stirred for 6 h at 50 C in a 100 mL methanolic solution with 0.75 
mL concentrated hydrochloric acid.  The template-removed solid product was then isolated 
via filtration and dried under vacuum at room temperature for 12 h. 
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3. Characterization of the MSN material.   
Surface analysis of the MSN materials was performed by nitrogen sorption isotherms at 77 K 
with a Micromeritics ASAP2000 sorptometer.  The surface areas were calculated by the 
Brunauer-Emmett-Teller (BET) method and the pore size distribution were calculated by the 
Barrett-Joyner-Halenda (BJH) method.  Small angle X-ray diffraction patterns were obtained 
with a Scintag XDS-2000 powder diffractometer using Cu Kα irradiation.  For transmission 
electron microscopy measurements, an aliquot of the powder was sonicated in nanopure 
water for 15 min.  A single drop of this suspension was placed on a lacey carbon coated 
copper TEM grid and dried in air.  The TEM examination was completed on a Tecnai G2 F20 
electron microscope operated at 200 kV to examine at electron optical magnification of 
64,000 to 550,000.  Particle size was measured in a Malvern Zetasizer Nano Series HT.  For 
the analysis the MSN were suspended in phosphate buffer saline solution (PBS, 10 mM 
phosphate and 75 mM sodium chloride) pH 7.4 at a concentration of 0.75 mg/ml and 
sonicated for 40 minutes.  The suspension was then transferred to a polystyrene cuvette and 
its particle size was measured, and the results were processed with DTS software version 
4.20.  
 
4. Labeling of cytochrome c.   
Cytochrome c (5.4 mg) was dissolved in 2.0 mL 0.1 M sodium bicarbonate solution pH 8.98.  
Fluorescein isothiocyanate isomer I (FITC) was dissolved in dimethyl sulfoxide at a 
concentration of 4 mg/mL, and 500 µL of this solution were added dropwise to the protein 
solution.  The mixture was stirred at room temperature for 2 h and then stirred for 12 h at 4 
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C, followed by the addition of ammonium chloride (21 mg).  The solution mixture was 
stirred for 2 h at room temperature.  The resulting FITC-labeled protein was then isolated by 
size exclusion chromatography with Sephadex G-25 as stationary phase and PBS as mobile 
phase.  The isolated FITC-cytochrome c was then characterized by ultraviolet-visible 
absorption spectroscopy, and the labeling efficiency was determined to be 1.8 moles FITC 
per mole of protein. 
 
5. Loading of cytochrome c into MSN.   
For the loading of FITC-cytochrome c to MSN, 5 mL of solutions of different concentrations 
of the protein ranging from 0.4 to 8 mg/mL in PBS were stirred for 6 h at room temperature 
in the presence of 20 mg of MSN in each solution.  The suspensions were then centrifuged 
and the loading was determined by measuring the difference in absorption of the Soret band 
of cytochrome c (410 nm) in the supernatant before and after the loading.  The isolated 
protein-MSN composites were dried in the dark at room temperature and under vacuum for 
12 h. 
 
6. Release of cytochrome c from MSN. 
The release of FITC-cytochrome c from MSN was measured by preparing suspensions of the 
FITC-cytochrome c-loaded MSNs in PBS at the concentration of 100 µg/mL.  The 
suspensions were kept at room temperature and the release was determined by taking an 
aliquot of the suspension at different times.  The aliquots were centrifuged and the UV-Vis 
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absorbance of the Soret band of cytochrome c in the supernatant was measured to give 
information on the quantity of released protein. 
 
7. Measurement of the ζ-potential variation of cytochrome c and MSN.   
The variation of the ζ-potentials of cytochrome c and MSN induced by different pH values of 
the aqueous solutions were measured by a Malvern Nano HT Zetasizer equipped with an 
MPT-2 autotitrator.  The ζ-potentials of cytochrome c and MSN were measured separately in 
non-buffered aqueous media at pH 4.5 of HCl(aq).  A specific amount of 0.135 M solution of 
sodium hydroxide was added by the titrator to obtain a stable pH and ζ-potential reading for 
all of the samples.  This process was repeated until the pH reached a value of 8.5. 
 
8. Measurement of the enzymatic activity of cytochrome c.   
The enzymatic activity of cytochrome c was measured by examining the catalytic conversion 
of the oxidation of 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonate) (ABTS) in a PBS 
solution of cytochrome c that was released from MSN overnight.  The cytochrome c 
employed for this assay was not labeled with FITC.  The concentration of cytochrome c in 
this solution was determined to be 21 g/mL by the UV-Vis absorption of the Soret Band of 
the protein.  The enzymatic activity of the MSN-released cytochrome c was compared with 
that of a solution of the protein directly dissolved in PBS solution.  This solution of 
cytochrome c was kept at room temperature overnight before measuring the catalytic 
performance, and its concentration was adjusted to be the same as the one of the cytochrome 
c released from the MSN.  Hydrogen peroxide (500 L, 25 mM) was then added to 500 L of 
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the cytochrome c solution in a polystyrene cuvette, followed by the addition of 300 L of 
ABTS.  The absorbance at 418 nm of the oxidized product was monitored every 30 sec for 7 
min.  A control experiment was performed by using an enzyme-free 500 L PBS solution. 
 
9. Measurement of the internalization of FITC-cytochrome c loaded MSN by HeLa 
cells.   
The cellular uptake profile of the protein-loaded MSN was examined by FACS flow 
cytometry.  For the assay, HeLa cells were seeded in 6-well plates with a density of 1 × 105 
cells/mL in 3 mL of D-10 medium.  The D-10 medium is a Dubelcco modified Eagle’s 
medium (DMEM) containing 10% equine serum, L-alanylglutamine, gentamicin, and 
penicillin/streptomycin.  After incubation for 34 h, the D-10 medium was replaced by 3 mL 
of MSN suspensions at concentrations 10, 25, 50, and 100 μg/mL in the D-10 medium for 12 
h.  All of the tests were run in triplicate.  The cells were washed with medium and harvested 
by trypsinization.  After centrifugation, the cell pellets were resuspended in 0.4 % trypan blue 
PBS solution, and analyzed by flow cytometry with a Becton-Dickinson FACSCanto 
cytometer and BD-FACS Diva software. 
 
To distinguish the true fluorescence generated by the loaded MSN from the natural 
autofluorescence of cells, a threshold of fluorescence intensity was established by performing 
the flow cytometry analysis on HeLa cells incubated without any MSN.  The threshold was 
set at an intensity of fluorescence slightly above the highest value observed for control 
105 
samples (HeLa cells only).  The number of cells with encytosed MSNs was determined by 
counting the cells showing fluorescence intensity higher than the threshold. 
 
10. Confocal fluorescence microscopy of HeLa cells with the FITC-cytochrome c loaded 
MSNs. 
For confocal fluorescence microscopy measurements, HeLa cells were seeded at a density of 
1 × 105 cells per well in 6-well plates in 3 mL D-10 medium with coverslips at the bottom of 
the wells.  Three samples were prepared for the microscopy study.  The first sample was 
prepared by incubating the cells for 24 h, followed by the replacement of the D-10 medium 
with 3 mL of the FITC-cytochrome c-loaded MSN (100 μg/mL) in the D-10 medium and 
allowed to grow for additional 50 h.  The second sample was prepared by an initial 
incubation in the D-10 medium for 50 h, followed by the replacement of medium with 3 mL 
of the FITC-cytochrome c-loaded MSN (100 μg/mL) in the D-10 medium and allowed to 
grow for 24 h.  The third sample was prepared by first incubating in the D-10 medium for 56 
h, followed by the replacement of medium with 3 mL of the FITC-cytochrome c-loaded MSN 
(100 μg/mL) in the D-10 medium and allowed to grow for 18 h.  
 
The cell-plated coverslips of these three samples were isolated, washed with medium, and 
fixed with 3.7 % formaldehyde in 100 mM PBS buffer pH 7.44 for 30 min.  The coverslips 
were then placed in microscope slides and examined under a Leica TCS NT confocal 
fluorescence microscope system using a 100x oil immersion objective.  The green fluorescent 
FITC-cytochrome c-loaded MSN particles inside of the HeLa cells were visualized by 
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excitation at 488nm with an Argon Laser and the autofluorescence images of the cells were 
obtained with a 568nm Krypton laser. 
 
11. Determination of endosomal escape of the FITC-cytochrome c loaded MSN.   
HeLa cells were seeded at the density of 1 × 105 cells per well in 6-well plates in 3 mL D-10 
medium with coverslips at the bottom of the wells.  Again, three samples were prepared for 
the microscopy study.  The first sample was prepared by incubating the cells for 24 h, 
followed by the replacement of the D-10 medium with 3 mL of the FITC-cytochrome c-
loaded MSN (100 μg/mL) and an endosome marker34 (FM 4-64; 10μg/mL) in the D-10 
medium and allowed to grow for additional 24 h.  The second sample was prepared by an 
initial incubation in the D-10 medium for 34 h, followed by the replacement of medium with 
the same MSN and endosome marker mixture in the D-10 medium and allowed to grow for 
14 h.  The third sample was prepared by first incubating in the D-10 medium for 46 h, 
followed by the replacement of medium with the same MSN and endosome marker mixture 
in the D-10 medium and allowed to grow for 2 h. 
 
The cell-plated coverslips of these samples were isolated and washed with medium, followed 
by a fixation with 3.7 % formaldehyde in 100 mM PBS buffer pH 7.4.  The coverslips were 
placed in microscope slides and examined under a Leica TCS NT confocal fluorescence 
microscope system using a 100x oil immersion objective.  Both, the FITC-cytochrome c-
loaded MSNs and the endosome marker were excited at 488 nm with an Argon Laser, the 
FITC-cytochrome c were detected at wavelengths between 515-590 nm (observed green), 
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while the endosome marker was detected at wavelengths between 590-750 nm (observed 
red).  The FITC-labeled proteins are considered to be inside of the endosomes, where the 
green and the red spots are overlapped to give a yellow/orange color.  The autofluorescence 
images of the cells were obtained with a 568 nm Krypton laser. 
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CHAPTER 5.  BIOCOMPATIBILITY STUDY OF MESOPOROUS SILICA 
NANOPARTICLES WITH RED BLOOD CELLS 
A paper submitted to Nano Letters 
Igor I. Slowing and Victor S.-Y. Lin 
 
Abstract 
Amorphous silica particles are toxic to red blood cells.  We studied the biocompatibility of 
mesoporous silica nanoparticles (MSN) with rabbit red blood cells.  The source of the 
hemolytic properties of amorphous silica and the effect of functionalization on those 
properties were analyzed.  We demonstrated that the unique structural characteristics of MSN 
prevent them from displaying hemolytic activity at the tested concentrations.  Based on these 
results, we envision MSN as safe candidates for in vivo drug delivery applications.  
 
 
Different forms of silica, including amorphous silica nanoparticles and mesoporous silica 
nanoparticles (MSN) have been proposed recently as candidates for drug delivery 
applications.
1, 2
  Such proposals are based, besides of a series of advantageous properties, on 
the observed biocompatibility of these materials with a variety of cell types.
3-7
  The low in 
vitro cytotoxicity of silica nanoparticles towards many kinds of mammalian cells is, however, 
no guarantee of their safety for in vivo applications.  In fact, amorphous silica has been long 
known to cause hemolysis when set in contact with red blood cells (RBC).
8
  Such a behavior 
draws serious concerns regarding the safe use of unmodified amorphous silica for drug 
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delivery applications involving intravenous administration and transport.  Many research 
groups have studied the hemolytic effects of amorphous silica and proposed a variety of 
explanations for such a property.  Among the causes believed to be responsible for that 
undesirable behavior we can mention the generation of reactive oxygen species by the surface 
of silica,
9 
denaturation of membrane proteins through electrostatic interactions with silica,
10
 
and the high affinity of silica for tetraalkylammonium groups that are abundant in the 
membranes of RBC.
11 
 It has been recently demonstrated that the hemolytic properties of 
amorphous silica are proportional to the concentration of silanol in its surface.
12
  It is 
surprising that even if the hemolytical properties of amorphous silica have been so well 
documented, there is, to the best of our knowledge, no report on the biocompatibility of MSN 
with RBC. 
MSN synthesized by our previously reported method,
3
 are spherical particles with 
diameters of ranging from 100 to 200 nm.  Their structure consists of a series of 
approximately 3 nm wide parallel channels arranged in a 2D hexagonal geometry (Figure 1).  
The high degree of order of the mesopores is reflected by their typical signals observed in 
powder X-ray diffraction.   These properties along with the large surface areas and pore 
volumes of MSN (close to 1,000 m
2
/g and 1 cm
3
/g respectively, see Supporting Information), 
make them highly convenient carriers for small and medium sized molecules.
3, 4, 7, 13-15
 
Considering that in our previous studies of endocytosis of MSN, efficient cellular uptake of 
the material was achieved at concentrations below 50 µg/mL and no cytotoxic effects were 
observed but at concentrations above 100 µg/mL, we decided to set a threshold concentration 
of 100 µg/mL to evaluate the compatibility of the material with RBC.
3, 5, 13
  As a control to 
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our experiments we used commercially available amorphous silica nanoparticles (Sigma 
Aldrich, Co., St. Louis, MO).  The hemolytic properties of the materials were evaluated on 
rabbit RBC, which were isolated from EDTA stabilized blood, by centrifugation and five 
successive washes with sterile isotonic phosphate saline buffered solution (PBS).  After the 
final wash the RBC were diluted to one tenth with PBS.  The diluted RBC suspension (300 
µL) was mixed with a suspension of the silica material to be tested (750 µL, 200 µg/mL) and 
the total volume was adjusted to 1500 µL with PBS.  Positive and negative controls were 
made by mixing the 300 µL of RBC suspensions with 1200 µL of nanopure water and PBS 
respectively.  After vortexing the samples, they were let to rest for 2 hours at room 
temperature.  The samples were then centrifuged for 10 min at 14,000 rpm and the absorption 
of the hemoglobin released in the supernatant was measured at 541 nm.  Amorphous silica, as 
expected, showed hemolytic properties.  However, surprisingly, MSN did not produce any 
hemolysis (Figures 2, 3, and Supporting Information). 
In order to determine if the hemolytic activity was related to the abundance of silanol 
groups, as it had been previously reported,
12
 solid state 
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SiNMR spectra were taken for both 
materials.  Surprisingly, the hemolytic amorphous silica showed a lower amount of silanol 
groups than the non-hemolytic MSN (Figure 4).  This result is even more puzzling 
considering the fact that upon measuring the ζ-potential of both materials, amorphous silica 
resulted being more negative (-49 mV) than MSN (-35 mV).  This apparent contradiction was 
solved upon considering the unique structural properties of MSN.  As can be noted in Figures 
1 and 5(b) the surface of MSN can be divided into two types, namely: an external and an 
internal surface.  It is easy to see that the internal surface, constituted by the mesopores, is by 
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far larger than the external one, which is limited mainly to the borders of the pore openings.  
This makes the number of silanol groups available to contact the surface of RBC significantly 
smaller than the amount of silanol groups present in the external surface of the amorphous 
silica particles.  The difference between the external surfaces of both materials is analogous 
to the comparison of the surface of a solid sphere with the one of a spherical net.  Therefore, 
even if MSN has a larger number of silanol groups than amorphous silica, most of these 
groups are unable to lead to the hemolysis of RBC, for they are “hidden” in the inside of the 
mesopores, and are consequently unable to get in contact with the cells (Figure 5).  These 
results suggest that it is less likely that the hemolytic properties of silica arise from the 
generation of reactive oxygen species by the silanol groups as previously proposed,
9
 than 
from the direct interaction of the silanol groups with the cell membrane surface. 
To further test the hypothesis of an electrostatic interaction of silica as the possible cause of 
the hemolysis of RBC, we functionalized the surfaces of the materials with groups that were 
expected to modify their surface charges.  As can be observed in Table 1, upon grafting 3-
aminopropyltrimethoxysilane on the surface of amorphous silica, its ζ-potential is completely 
inverted and this results in a dramatic decrease of the hemolytic property of the material.  
Furthermore, upon functionalizing MSN with a benzenesulfonic moiety its ζ-potential is 
shifted to a value even more negative than the one of amorphous silica, and the resulting 
material clearly displayed hemolytic activity. 
The conclusion, however, is not as straightforward as it appears to be.  The hemolytic 
properties of silica seem to involve more than a simple electrostatic interaction.  To further 
test if particle charge is the only property required to produce hemolysis, we functionalized 
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MSN with carboxylic acid terminated chains, in a quantity enough to achieve a ζ-potential 
comparable to the one of amorphous silica.  Surprisingly, despite its highly negative ζ-
potential (-50 mV), the resulting material did not show significant hemolytic activity (less 
than 4%).  This result shows the hemolytic activity of silica has a more subtle origin, 
probably related to a special affinity existing between silica and the membrane lipids.  The 
lipids of the external leaflet of the membranes of RBC are particularly abundant in 
sphingomyelin and posphatidylcholine, whose polar heads end in a trimethylammonium 
group.
16 
 The affinity between silica and lipids containing trimethylammonium head groups, 
is well known.
17-19
 A good example of this affinity is precisely the use of 
alkyltrimethylammonium surfactants as templates for the polymerization of silica to yield 
ordered mesoporous materials.
20
  A measure of this interaction is given by the negative value 
of the heat of displacement of water from the surface of silica by 
hexadecyltrimethylammonium ions at low concentrations.
21
  Furthermore, benzenesulfonates 
have been shown also to have stronger affinities for alkyltrimethylammonium ions than 
carboxylates: the enthalpies of transfer from water to a cetyltrimethylammonium solution 
were found to be negative for sodium benzenesulfonate, but positive for sodium acetate.
22, 23
  
The affinities of anions for alkyltrimethylammonium species have been shown to correlate 
well with the Hofmeister series.
22
   It has been also reported that following the Hofmeister 
series, anions are increasingly able to penetrate a lipid layer and disrupt the packing of the 
hydrophobic chains.
24
  Based on this information we believe it is plausible that silica and 
benzenesulfonate functionalized silica are able to produce the hemolysis of RBC because of 
their high affinity for trimethylammonium headgroups of the membrane lipids. This explains 
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also why in spite of its highly negative ζ-potential, MSN functionalized with carboxy groups, 
which have low affinity for trimethylammonium ions, display little hemolytic activity. 
In conclusion, we have demonstrated that contrary to the known cytotoxicity that silica 
displays towards RBC, MSN are biocompatible with this type of cells at concentrations 
adequate for potential pharmacological applications.  We have shown that the unexpected 
compatibility of MSN arises from the little amount of silanol groups available for interaction 
with the RBC membranes, which is a unique structural characteristic of the material.   We 
have demonstrated that the hemolytic property of silica is related only to the amount of 
silanol groups accessible to the cell membrane, and that the cytotoxic effect is probably 
related to the disruption of the membrane through attractive interactions with 
trimethylammonium head groups of the membrane lipids.  This study provides a contribution 
to the understanding of a health problem that has been debated for a long time.  Based on 
these results we envision MSN as a safe candidate for in vivo drug delivery applications.   
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Table 1. Relationship between ζ-potential of the materials and their ability to produce 
hemolysis of RBC. 
 ζ-potential [mV] % Hemolysis 
Amorphous silica - 49 90 
MSN - 35 0.3 
Aminopropyl grafted amorphous silica + 27 1 
Ethylbenzenesulfonato functionalized MSN - 90 61 
Materials at a concentration of 100 µg/mL. 
117 
Figure captions. 
Figure 1. Transmission electron micrograph of MSN. 
 
Figure 2. Mixtures of RBC with (a) amorphous silica, (b) PBS (negative control) and (c) 
MSN.  The mixtures were centrifuged to detect the presence of red color in the supernatants, 
which corresponds to hemoglobin released from the RBC. 
 
Figure 3. Phase contrast images of RBC after 24 hours in contact with 100 µg/mL 
suspensions of (a) amorphous silica, and (b) MSN. 
 
Figure 4. DP MAS 29Si NMR of (a) amorphous silica, and (b) MSN.  CP MAS 29Si NMR of 
(c) amorphous silica, and (d) MSN.  It can be noted that amorphous silica has a large Q
4
 and 
a hardly identifiable Q
3
 signal, while in MSN both peaks do have similar intensities. 
 
Figure 5. Representation of (a) amorphous silica, and (b) MSN.  The cartoons show the 
expected differences between the locations of the silanol groups in the surfaces of both 
materials. 
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Appendix: Supporting Information 
 
1. Synthesis or the materials 
Tetraethylorthosilicate (TEOS), 2-(4-chlorosulfonylphenyl)ethyltrimethoxysilane 
were purchased from Gelest.  3-aminopropyltrimethoxysilane, 3-mercaptopropyl-
trimethoxysilane, cetyltrimethylammonium bromide (CTAB), Aldrithiol-2
®
, 3-
mercaptopropionic acid were purchased from Sigma-Aldrich.  All chemicals were used as 
received. 
 
1.1 Synthesis of Mesoporous Silica Nanoparticles (MSN). 
A mixture of CTAB (1.02 g, 2.66 mmol), water (480 mL) and sodium hydroxide (2 
M, 3.5 mL), was heated at 80
o
C under vigorous stirring.  TEOS (5.0 mL, 22 mmol) was then 
added dropwise to the reaction mixture, the temperature was maintained at 80
o
C for 2 h, after 
which the resulting white colored solid was filtered, washed with abundant methanol and 
dried under vacuum overnight. 
 
1.2 Synthesis of 2-(4-sulfonatophenyl)ethyl-MSN. 
For the synthesis of the sulfonic acid functionalized MSN, the procedure described in 
1.1 was slightly modified by adding mesitylene (7 mL) to the original CTAB mixture and 2-
(4-chlorosulfonylphenyl)ethyltrimethoxysilane (1.5 mL,  3.0 mmol) dropwise immediately 
after the addition of TEOS. 
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1.3 Grafting of functional groups on amorphous silica and MSN. 
The functionalization of amorphous silica with 3-aminopropyl groups and of MSN 
with 3-mercaptopropyl groups was performed by refluxing a suspension of the silica material 
(1 g of amorphous silica or MSN prepared as indicated in section 1.1) with the 
trialkoxysilane precursors of the corresponding functional group (5  mmol) in 100 mL 
Toluene for 20 h.  After that time the products were filtered, washed with methanol and dried 
under vacuum overnight. 
1.4 Preparation of carboxylate functionalized MSN. 
A solution of Aldrithiol-2
® 
(99.0 mg, 0.44 mmol) in 5.0 mL methanol was added to a 
suspension of 3-mercaptopropyl functionalized MSN (300 mg, prepared from procedure 1.3) 
suspended in 15.0 mL methanol.  The resulting suspension, which was changing from white 
to light yellow as the reaction was progressing, was stirred at room temperature for 24 h.  
After that time the resulting white solid was recovered by filtration, and was washed with 
abundant methanol.  The yellow filtrate was discarded with the washes.  The amount of 
aldrithiol reacted was determined to be 0.191 mmol by absorption of the by product in the 
supernatant and the combined washes at 354 nm. 
The washed solid was resuspended in 5 mL methanol.  3-mercaptopropionic acid (100 
µL, 1.13 mmol) was then added to the suspension under stirring at room temperature.  The 
mixture that turned almost immediately from white to light yellow was kept stirring at room 
temperature for further 24 h.  After that time the product was filtered and washed with 
abundant methanol.  The amount of mercaptopropionic acid reacted was determined to be 
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0.0738 mmol by absorption of the by product in the supernatant and the combined washes at 
354 nm.  The resulting white solid was then dried under vacuum overnight. 
 
1.5 Removal of the template surfactant from MSN and from functionalized MSN. 
The CTAB surfactant was removed from the MSN obtained from the procedures 1.1, 
1.2 and 1.4, by refluxing a suspension of the corresponding solid (1.0 g) in 100 mL methanol 
for 6 h.  Following the reflux the resulting solid was filtered, washed with abundant methanol 
and dried under vacuum overnight. 
 
2. Characterization of the materials. 
2.1 X-ray diffraction analysis. 
Powder X-ray diffraction patterns were obtained in a Scintag XDS-2000 
diffractometer using Cu Kα irradiation.  All of the MSN materials do possess the hexagonal 
structure typical of MCM-41 with the characteristic (100), (110) and (200) signals. 
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Figure SI 1. X-ray diffraction patterns of (a) MSN, (b) 3-aminopropyl-MSN and (c) (4-
sulfonatophenyl)ethyl-MSN. 
(c) 
(a) 
(b) 
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2.2 Nitrogen sorption analysis of MSN. 
The surface properties of the MSN materials were analyzed in a Micromeritics Tristar surface 
area and porosity analyzer, with analysis software Tristar 3000 version 6.05. 
 
 
 
 
 
AP MSN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure SI 2. Nitrogen sorption isotherm and pore size distribution plots of (a) MSN, (b) 3-
aminopropyl-MSN and (c) 4-(sulfonatophenyl)ethyl-MSN. 
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2.3 ζ-potential measurements. 
The surface charge of the materials was measured in a Malvern Nano HT Zetasizer ZS90, 
processed with Dispersion Technology Software version 4.20.  The measurements were 
performed on 1 mg/mL suspensions of each material in buffer solution containing sodium 
phosphates (1 mM) and sodium chloride (15.4 mM) set at pH 7.4. 
 
2.4 Hemolysis assay. 
Rabbit blood stabilized with EDTA was obtained from the Laboratory Animal Resources 
office of Iowa State University.  The serum was removed from the blood by centrifugation 
and suction, and the red blood cells were then washed five times with sterile isotonic PBS 
solution.  Following the last wash the cells were diluted to 1/10 of their volume with sterile 
isotonic PBS solution. 
 
The diluted RBC suspension (200 µL) was then mixed with: a) 1300 µL of PBS as a negative 
control; b) 1300 µL nanopure water as a positive control; c) 1300 µL of a suspension of the 
silica materials of interest at a concentration of 115 µg/mL.  The mixtures were then vortexed 
and then let to rest for two hours at room temperature.  After that time the samples were 
centrifuged and the absorbances of the supernatants at 541 nm were measured in a HP 845x 
UV-Visible station.  The percent hemolysis of each sample was calculated by dividing the 
difference of absorptions of the sample and the negative control, by the difference of 
absorptions of the positive and the negative controls, and multiplying the resulting ratio by 
100. 
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CHAPTER 6.  GENERAL CONCLUSIONS 
 
In view of the growing interest in the development of smart vehicles for intracellular 
delivery of drugs or biologically active molecules, a series of materials have been recently 
synthesized, such materials include among others, quantum dots, carbon nanotubes and silica 
nanoparticles.  Joining these efforts Victor Lin’s group at Iowa State University has 
developed mesoporous silica nanoparticles (MSN) and has provided initial results for their 
use as intracellular delivery vehicles.  This dissertation has provided a deeper analysis of the 
interactions of MSN with animal cells and has shown how functionalization and structure 
modification can regulate and control their membrane transport capabilities. 
In order to optimize the properties of MSN for applying them as intracellular 
molecular cargos it is necessary to understand the mechanism of their internalization into 
cells.  It has been demonstrated in this work that even if the uptake of MSN by cells is not 
receptor-mediated, it is an energy dependent process involving clathrin coated pits.  The 
modification of the surface of MSN however, was shown to induce changes in the uptake 
mechanism, either by invoking the response of specific receptors or by shifting the 
internalization to a non-clathrin dependent pathway.  Furthermore this work demonstrated 
that surface functionalization of the material is able to induce differences in the efficiency of 
the uptake either through electrostatic matching or through the participation of groups for 
which the cells do have receptors.  It was also found that an increase in uptake efficiency 
does not necessarily imply improved cytosolic delivery, for the intracellular fate of the 
material is also dependent on the nature of its surface.  It was observed that materials with 
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surface properties that enabled them to be up taken in high degree by the cells were less able 
to reach the cytoplasm, remaining trapped in intracellular vesicles.  It was thus demonstrated 
that in order to prepare an efficient intracellular delivery agent, the surface properties have to 
be fine tuned so as to enable not only internalization but also endosomal escape. 
Besides of the capability of modifying the surface of MSN, it is desirable to be able to 
tune their structure so as to provide a reservoir with a size that matches the size requirements 
of the guest molecules.  It was demonstrated in this work that it is possible to adjust the pore 
size of MSN so that it is able to host biomolecules such as proteins.  Pore enlarged MSN 
were shown to be able to adsorb up to 40% of their mass with cytochrome c, and were able to 
slowly release the protein upon resuspension in buffered medium.  The protein released from 
the MSN was shown to completely retain its enzymatic activity.  The introduction of the 
fluorescently labeled protein into living cells by means of MSN was evidenced by flow 
cytometry and confocal microscopy, and the release of the pro-apoptotic protein cytochrome 
c into the cytosol was observed by the spreading of the dyed molecules throughout the whole 
cell body and through the observation of large intracellular vacuoles, characteristic of 
apoptotic cells.  This work demonstrated that pore enlarged MSN can be efficiently employed 
to deliver membrane impermeable proteins into living cells. 
Since silica particles have been long known to be cytotoxic to red blood cells, the 
possibility of using MSN for in vivo delivery applications was in question.  In this work it 
was demonstrated that as opposed to non-porous silica, and because of their unique structure, 
MSN are not able to expose a continuous surface for disruptive interaction with the 
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membrane of red blood cells.  The work demonstrated that only upon functionalizing MSN 
with the highly negative benzenesulfonate groups, did they acquire hemolytic properties. 
This dissertation represents a significant contribution to establish the chemical and 
structural characteristics that are prerequisites for the application of MSN as safe intracellular 
delivery agents, and thus opens the doors for the future in vivo studies of the material.  
Further work is required to understand the mechanism of endosomal escape by the material, 
as well as its long term fate.  Future developments of the material are expected which may 
include the achievement of cell type selectivity both in terms of uptake and release, and the 
use of the material for interfering with intracellular processes through the sequestration of 
bioactive molecules. 
